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Abstract:
Pulmonary surfactant is a lipoprotein mixture responsible for reducing surface
tension of the lung. In this thesis, we investigate the impact of lung injury on surfactant
composition and function, with a specific focus on cholesterol content. First, the impact
of a high cholesterol diet on surfactant function was assessed in three models of lung
injury. It was hypothesized that serum hypercholesterolemia would increase host
susceptibility to surfactant functional impairments. Secondly, the impact of injurious
ventilation on intracellular surfactant within the lung was investigated. It was
hypothesized injurious ventilation would produce alterations to lamellar body surfactant.
Overall, the data suggest that a high cholesterol diet contributes to altered surfactant
function during lung injury. Additionally, injurious ventilation promoted functional
impairments to intracellular surfactant prior to secretion into the airspaces. In conclusion,
we provide evidence of diet induced alterations to surfactant function and novel insight
into intra-alveolar alterations to surfactant during mechanical ventilation.

Keywords: Pulmonary surfactant, mechanical ventilation, ventilation induced lung
injury, lamellar body, minimum surface tension, cholesterol, acute respiratory distress
syndrome.
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Chapter 1 - General Introduction and Literature Review

1.1 Overview
Pulmonary surfactant is a significant contributor toward normal respiratory
mechanics and arterial blood oxygenation. Surfactant is a complex mixture composed
primarily of phospholipids, surfactant-associated proteins, and neutral lipids such as
cholesterol. Secreted into lung airspaces, surfactant’s function is to reduce surface tensions,
which helps to facilitate breathing and prevent alveolar collapse at low lung volumes
(West, 1995). The specific constituents of surfactant are important for its ability to reduce
surface tension while alterations to surfactant composition may contribute to its
dysfunction and impaired arterial oxygenation.
Acute respiratory distress syndrome (ARDS) is a severe respiratory disorder with a
high mortality. Patients with ARDS present with a variety of pathological changes in the
lung (Ware and Matthay, 2000), however across all causes of ARDS, dysfunctional
surfactant forms contribute to impairments in surface tension reduction and gas exchange
(Günther et al., 2001). In order to accurately reverse low arterial oxygenation in these
patients, mechanical ventilation is employed as a supportive therapy to promote gas
exchange in the lungs. Unfortunately, the use of mechanical ventilation in pre-injured lungs
or through the use of inappropriate ventilation strategies may promote lung injury via
localized over-distension of the healthy lung regions and repeated alveolar collapse. The
generation of these damaging forces may induce or exacerbate alterations to the surfactant
system, further contributing to poor lung function and patient survival (Tremblay and
Slutsky, 2006).
The purpose of this thesis was to investigate the role of diet induced serum
hypercholesterolemia and intracellular surfactant alterations within the context of
surfactant function following exposure to injurious mechanical ventilation of the lung. This
introductory chapter focuses on basic concepts such as structure and function of surfactant,
mechanical ventilation of the lung, and finally pathological alterations to surfactant
typically associated with mechanical ventilation.
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1.2 Structure and Function of Lungs
The primary function of the lung is to facilitate the exchange of O2 and CO2
between the external environment and the blood. Gas exchange is facilitated by the
respiratory cycle which consists of both inspiration and expiration. Inspiration begins with
contraction of the diaphragm and intercostal muscles, increasing the volume of the thoracic
cavity and creating a negative intrathoracic pressure relative to the external environment.
Due to this pressure gradient between the external environment and intrathoracic cavity,
approximately 0.5L of air from the external environment flows into the lungs causing them
to inflate (West, 1995). This volume of inspired air at each breath is called the tidal volume
(VT) and is ~6-8mL/kg in humans. Expansion of the lungs during inspiration helps to
promote the formation of a large surface area at which O2 from the external environment
and CO2 from the blood may be exchanged. Following inspiration, the diaphragm and
intercostal muscles relax and the chest cavity decreases in volume, returning lungs to their
equilibrium position, expelling air and CO2 in a process called expiration.
The structure of the lungs makes this organ well suited for gas exchange as the
lungs form a branching network of airways that get increasingly smaller in diameter toward
the distal regions. At the ends of these airways are millions of small air-sacs called alveoli.
The alveolar tissue is well perfused with blood from nearby capillaries, which provide a
short diffusion distance (~0.3µm) between the external environment and the systemic
circulation allowing for efficient gas exchange. The high number and small size of these
alveoli contribute to a large surface area of up to 50-100m2 at which gas exchange can
occur (West, 1995). Because of these factors, the alveoli allow for efficient gas exchange,
producing high partial pressure of arterial blood oxygen (PaO2 = 85-100mmHg, PaO2:FiO2
= 400-500mmHg) and relative low partial pressure of carbon dioxide (PaCO2) in the blood
(37-43mmHg), satisfying the metabolic demands of systemic tissues (West, 2003).
The surface of the alveolus is composed of two types of cells; alveolar type I, and
a smaller proportion of alveolar type II epithelial cells (AIIE). Directly between the
alveolar surface and the nearby airspace is a thin lining of aqueous fluid, termed the
alveolar hypophase, which extends from the interior of alveolar sacs where it is secreted,
into the lung’s airways. This aqueous fluid exerts a large force (or surface tension) upon
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the lung, causing a high energy requirement for recruiting the alveolar sacs. Fortunately,
AIIE cells near the airspaces secrete a surface active phospholipid-protein mixture, called
surfactant, into the alveolar hypophase in order to counteract these forces which ultimately
facilitate the ease of respiration. Alveolar type I cells, although not the focus of this thesis,
have an important role as their elongated structure creates the large, thin alveolar surface
that allows for efficient gas exchange.
The remarkable ability of the lungs to efficiently exchange gases during respiration
is highly dependent on pulmonary surfactant which is responsible for promoting high
pulmonary compliance (i.e. the change in lung volume associated with a given distending
pressure) by reducing these high surface tensions of the alveolar hypophase. High
compliance allows the lungs to easily inflate upon relatively small changes in intrathoracic
pressure helping to facilitate respiration. Furthermore, this phospholipid-protein mixture
prevents the collapse of alveolar sacs by maintaining stability at low lung volumes (i.e.
during exhalation). The importance of surfactant for reducing surface tension in the lung
and its subsequent impact on respiratory function will be discussed in the following
sections.

1.2.1 – Surface Tension
The primary function of surfactant within the lung is to reduce the high surface
tensions at the air-liquid interface of the alveolar hypophase. In order to sufficiently
understand the actions of surfactant in the lung, a thorough understanding of the concept
of surface tension is required. Presented in Figure 1.1 is the basic concept of how surface
tension arises at an interface. Water molecules within the bulk of the aqueous solution are
surrounded by other molecules in each direction, resulting in a molecule at equilibrium
with no net force in any direction. However, molecules within 1nm of the air-liquid
interface do not possess equal attractive forces between air vapour molecules above
compared to those within the aqueous hypophase (Zinke-Allmang, 2009). The result of
these unbalanced electrostatic forces is a net force driving the interfacial molecule into the
bulk phase (Figure 1.1A). The electrostatic imbalance at the interface produces a high
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energy requirement for the formation of a surface, as molecules must be moved to the
interface against these net forces. This force required for a surface film to resist expansion
is called surface tension, which is measured as force/unit area (Possmayer, 1992). This
phenomenon produces a tendency for materials with high surface tension such as water
(surface tension of 70mN/m at 37°C), to minimize surface area by forming shapes such as
spheres or droplets, while materials with low surface tensions form puddles.

Figure 1.1 – The generation of high surface tension at an aqueous air-liquid interface (A).
Phospholipids lower surface tension by forming an interfacial film and reducing the
magnitude of the net downward force on interfacial aqueous molecules beneath the surface.
(B). PL-phospholipid (Electrostatic forces are indicated by arrows, the magnitude of the
force is indicated by size of the arrow).

1.2.2 – How Surfactant Reduces Surface Tension
Surfactant aids in surface tension reduction by adsorbing to the air-liquid interface
and orienting in such a way that the polar head groups are contained within the bulk phase
forming a monolayer, while hydrophobic acyl tails protrude into the airspaces above. The
molecular orientation of the phospholipid molecules creates electrostatically favourable
interactions between the charged phospholipid head and the aqueous molecules near the
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lining of the air-liquid interface, reducing the net downward force on the interfacial water
molecules (Figure 1.1B). When this happens, the intermolecular attractive forces
responsible for generating high surface tensions are reduced (West, 1995).
The physiological impact of surfactant on pulmonary surface tension within the
alveolus is best illustrated using LaPlace’s law [1], applied to a bubble.
∆𝑃 = 2𝛾/𝑟

[1]

Where ∆P is the pressure difference across the drop or alveolus, γ is the surface tension
within the alveolus, and r is the radius of the alveolus. How surfactant stabilizes the
alveolus is shown in Figure 1.2. According to LaPlace’s law, as the radius of the alveolus
decreases during exhalation, the pressure across the alveolus increases if surface tension
remains the same. Surfactant acts to reduce the surface tension of the alveolar hypophase,
therefore reducing the pressure across alveoli at a given radius. Because alveolar size in
the lung is not uniform, higher surface tensions in the lung would produce a larger pressure
gradient across smaller alveoli, promoting the tendency for these alveoli to collapse inward,
shunting air toward the larger, more stable alveoli. Furthermore, a key feature of surfactant
is that surface tension is further reduced to near 0mN/m values during instances of lateral
compression due to an enrichment of tightly packed saturated phospholipids at the
interfacial film. Therefore surfactant at the air-liquid interface reduces the tendency of
alveolar collapse by increasing alveolar stability through surface tension reduction at low
lung volumes (Clements et al., 1961).
The reduction of surface tension within the alveolus is highly dependent on
surfactant’s composition, as biochemical alterations have been shown to contribute to
impairments in surface tension reduction. The interactions between surfactant constituents
in the alveolar hypophase create a large multi-layered scaffold capable of reducing surface
tension to low values.
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Figure 1.2 – LaPlace’s Law applied to a bubble (inverse configuration), modelling the
alveolus. Surfactant reduces surface tensions at the air-liquid interface, thereby reducing
pressure across the alveolus, contributing to alveolar stability and preventing collapse at
low lung volumes. γ -surface tension.
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1.3 –Surfactant Composition, Lifecycle, and Biophysical Function
Surfactant within the alveolar airspaces is crucial for reducing surface tension in
the lung. Several factors are responsible for surfactant’s ability to reduce surface tension
once secreted into the airspaces, including 1) proper composition and 2) maintenance and
metabolism of the interfacial surface film.

1.3.1- Surfactant Composition
The composition of surfactant constituents has been widely studied and is generally
well conserved across most mammalian species (Veldhuizen et al., 1998; Orgeig and
Daniels, 2001). Surfactant consists of a complex mixture of a variety of phospholipid
species (80-90% by weight), surfactant proteins A through D (5-10%), and neutral lipids the majority of which are cholesterol (4-10%) (Pérez-Gil, 2008; Zuo et al., 2008).
The single most prevalent surfactant component is phosphatidylcholine (PC)
composing 70 - 85% of all lipids. Of the PC found in surfactant, 30-60% is composed of
saturated dipalmitoylphosphatidylcholine (DPPC), consisting of two palmitic acids (16:0)
attached to a glycerol backbone (Kyriakides et al., 1976; Burnell et al., 1978; Zuo et al.,
2008). The remaining portion of PC is predominately composed of a variety of unsaturated
phospholipids (Zuo et al., 2008). Beyond PC, other phospholipid species, most of which
are unsaturated, make up the remaining portion of surfactant phospholipids including:
positively charged phosphatidylethanolamine (3-10%), negatively charged phospholipids
such as, phosphatidylinositol (2-4%) and phosphatidylglycerol (PG) (7-10%), and
sphingomyelin (2-3%) (Rooney et al., 1975; Post et al., 1982; Veldhuizen et al., 1998; Zuo
et al., 2008). In addition to phospholipids, neutral lipids make up the other lipid portion of
surfactant. The majority of neutral lipids in surfactant consist of free and esterified
cholesterol, while other tri-, di-, and mono-glycerides contribute to the smaller remaining
lipid pool (Post et al., 1982; Orgieg and Daniels, 2001). Although the phospholipid and
cholesterol constituents in surfactant are generally fairly consistent within a species, it has
been reported that intake of certain diets may impact its lipid composition (Davidson et al.,
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1997; Murray et al., 2000; Wolfe et al., 2002; McCrae et al., 2008). However the functional
consequences of these changes in surfactant composition remain poorly characterized.
Finally, surfactant contains four surfactant proteins including large hydrophilic
proteins, surfactant protein A (SPA) and surfactant protein D (SPD), and two smaller
hydrophobic proteins, surfactant protein B (SPB) and surfactant protein C (SPC) (Weaver
and Conkright, 2001; Haagsman and Diemel, 2001; Perez-Gil, 2008). SPA, a member of
the collectin family of proteins, makes up the majority of surfactant proteins by mass (~5%
total), while SPB, SPC, and SPD each compose a lesser proportion. These surfactant
proteins tend to associate with surfactant phospholipids with the exception of SPD. For this
reason, discussion of SPD will largely be excluded from this thesis (for detailed review,
see Hartl and Griese, 2006). The hydrophobic proteins SPB and SPC associate with
phospholipids acyl tails within surfactant and are vital for endogenous surfactant
biogenesis and function (Serrano and Pérez-Gil, 2006). Furthermore, SPB is positively
charged allowing for interactions with negatively charged phospholipids such as PG
(Weaver and Conkright, 2001).
The presence and proper ratio of these above surfactant constituents are paramount
for the proper function of surfactant films (Zuo et al., 2008). Furthermore, the processes
involved in the formation of surfactant at the air-liquid interface to mediate surface tension
reduction are highly dynamic. Surfactant is continuously produced, secreted and
metabolized within the lung in order to promote the formation of a film capable of
achieving optimal biophysical function during respiration.

1.3.2 - Alveolar Surfactant
The AIIE cells at the alveolar surface are constantly producing, secreting, reinternalizing, and recycling the surfactant mixture that covers alveolar epithelial surfaces
(Perez-Gil and Weaver, 2010). Within the healthy lung at any given time there are two
broad localizations of surfactant: 1) intracellular surfactant, such as lamellar bodies, acting
as surfactant storage vesicles within AIIEs, and 2) extracellular surfactant within the
alveolar hypophase of the airspaces forming a structurally dense 3D multilayer network of
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surfactant bilayers at the air-liquid interface, directly responsible for surface tension
reduction. There exists a dynamic turnover between these two localizations of surfactant;
intracellular lamellar bodies are secreted into the airspace where internal contents are
unravelled to form multilayers and a surface active film. In response to changes in surface
area that occur during respiration, surfactant constituents no longer contributing to surface
tension reduction, disassociate from the multi-layer network to form unilamellar vesicles
which are eventually internalized and recycled by the AIIE into new surfactant constituents
or targeted for degradation (Figure 1.3).
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Figure 1.3 – The endogenous pulmonary surfactant system. 1. Surfactant components are
first produced within AIIE cells and packaged into lamellar bodies. 2. Upon cellular
stimuli, lamellar bodies fuse with the apical plasma membrane and expel and unravel
internal surfactant bilayers into the airspaces, where it may associate with SPA to form
multilayer networks. 3. Multi-layer large aggregate structures form a monolayer and
surface membrane phase acting as surfactant associated surface reservoir (enlarged
portion). 4. During alveolar surface area cycling, inactive unilamellar vesicles are formed
and targeted for recycling within the AIIE. Note: not shown are surfactant proteins or the
graphical representation of cholesterol within the phospholipid bilayer phases.

1.3.2.1 - Intracellular Surfactant Production and Secretion
Surfactant production begins in the AIIE where phospholipid and surfactant protein
constituents are intracellularly synthesized and packaged together with cholesterol from
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the serum into bilayers along the cell exocytic pathway. The primary intracellular storage
vesicle for surfactant prior to its secretion into the airspace is the lamellar body. Lamellar
bodies are composed of dense, tightly packed stacks of lipid bilayers with proteinaceous
cores surrounded by an external limiting membrane (Gil and Reiss, 1973; Ochs, 2010).
Although other less abundant intermediate surfactant storage vesicles exist within the AIIE,
such as multivesicular bodies, the lamellar body represents final intracellular ‘precursor’
before secretion into the airspaces (Schmitz and Müller, 1991).
In the AIIE, the majority of surfactant phospholipids, including PC and PG, are
synthesized and remodelled in the endoplasmic reticulum (ER) (Batenburg, 1992; Schmitz
and Müller, 1991). Following synthesis, phospholipids are packaged into multivesicular
vesicles and continue along the exocytic pathway. During multivesicular body maturation
into lamellar bodies, additional phospholipids from the ER may transverse the lamellar
body limiting membrane into the lumen via lipid transporters such as ABCA3, promoting
the accumulation of lipids in the lamellar body cores (Perez-Gil and Weaver, 2010).
In addition to the surfactant phospholipids, SPB and SPC are synthesized within
the ER prior to concentration into secretory vesicles which mature into lamellar bodies
(Weaver, 1998; Haagsman and Diemel, 2001). These surfactant proteins are vital for the
phospholipid bilayer accumulation and organization into dense lamellae within lamellar
bodies; lack of SPB production results in respiratory deficiency and impaired maturation
of lamellar bodies from multivesicular structures (Clark et al., 1995; Melton et al., 2003).
The production and trafficking of SPA to surfactant membranes is less clear. Although
studies have previously localized SPA within lamellar bodies of AIIEs (OosterlakenDijksterhuis et al., 1991a), it has become widely accepted that the majority of SPA is
secreted independently of lamellar bodies from the ER into the air-spaces (Ochs et al.,
2002; Pérez-Gil, 2008).
Incorporation of cholesterol into surfactant phospholipid membranes normally
occurs during lamellar body formation. Hass and Longmore have previously demonstrated
that the majority of surfactant cholesterol (99%) is derived from serum lipoproteins rather
than endogenous synthesis (Hass and Longmore, 1979). However, less is known
concerning intra-alveolar trafficking of cholesterol from the serum into these surfactant
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storage organelles once inside the AIIE (Orgeig and Daniels, 2001; Gowdy and Fessler;
2013).
Once all surfactants constituents have been assembled into mature lamellar bodies,
cellular stimuli such as alveolar stretch (Dietl et al., 2010), triggers intracellular Ca2+
accumulation (Wirtz and Dobbs, 1990) promoting lamellar body exocytosis at the apical
membrane of the AIIE. Fusion of the limiting membrane at the apical plasma membrane
ultimately unravels the dense phospholipid bilayers and protein cores into the aqueous
hypophase.

1.3.2.2 – Extracellular Surfactant and Metabolism
Upon lamellar body secretion, the dense folds of phospholipid membranes from
within lamellar body cores form a large multi-layer network of bilayers in the alveolar
hypophase (Fig 1.3). At the alveolar air-liquid interface is a surface film which is connected
with the multilayer surfactant reservoir below. The formation of this multilayer structure
is thought to be aided through lipid-protein interactions mediated by SPA (Schürch et al.,
1992; Perez-Gil, 2008), SPB (Nag et al., 1999; Serrano and Perez-Gil, 2006) and SPC
(Leonenko et al., 2007). It is these extracellular surfactant structures that are directly
responsible for reducing the surface tension in the lung. Although extracellular surfactant
was previously conceptualized as a simple monolayer, visualizations of the air-liquid
interface have demonstrated surfactant solutions form a series of dense phospholipid
multilayers just below the surface monolayer (Schürch et al., 1998; Leonenko et al., 2007;
Follows et al., 2007; Ochs, 2010). To this end, surfactant should be conceptualized as a
complete structure developed in the aqueous lining as a whole termed the ‘membrane
surface phase’, rather than a simple interfacial monolayer (Perez-Gil, 2008). The
membrane surface phase complexes are experimentally described as large aggregates and
may be isolated from the airspaces of the lung by washing the lungs with fluid, a technique
known as broncho-alveolar lavage.

Previous estimates have suggested extracellular

surfactant concentration within the alveolar hypophase is quite high (Zuo et al., 2008), with
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phospholipid concentration estimations of 30 – 120 mg/mL found in adult small mammal
lungs (Ohashi et al., 1994; Putz et al., 1994).
The surfactant lining the alveolar surface is constantly exposed to compression and
expansion during respiration, resulting in changes in alveolar surface area. During
interfacial surface area cycling, spent or inactivated surfactant components from the
surface membrane phase disassociate to form small unilamellar vesicles, experimentally
referred to as small aggregates (Veldhuizen et al., 1996; Ito et al., 1997; Günther et al.,
1999). Previous studies have demonstrated these unilamellar vesicles do not possess
surface tension reducing capabilities (Yamada et al., 1990; Veldhuizen et al., 1993).
Although it has been demonstrated these small aggregates are composed of similar lipid
species as large aggregates, it has been suggested that small aggregates may be devoid of
SPB protein (Veldhuizen et al., 1993; Günther et al., 1999). Unilamellar vesicles that
dissociate into the hypophase may subsequently be internalized into the AIIE where the
constituents may be recycled into new surfactant membranes or degraded (Batenburg,
1992; Perez-Gil and Weaver, 2010).
Extracellular surfactant forms a structurally dense 3D network within the alveolar
hypophase that is directly responsible for surface tension reduction, helping to stabilize the
lung during respiration. The surface active properties of these extracellular films are
discussed in the following section.

1.3.3 Surfactant Biophysical Properties
For surfactant within the airspaces to be truly effective during respiration, it must
possess several important properties which will be referred to as surfactants ‘biophysical
properties’. Biophysical properties of a competent surfactant are I) rapid adsorption to the
air-liquid interface upon initial introduction to the hypophase (in vitro), II) achievement of
very low surface tension (~0mN/m) upon lateral compression, and III) efficient respreading to the air-liquid interface upon re-expansion (Zuo et al., 2008; Possmayer et al.,
2010). Although surfactant is important for in vivo lung stability and function, the current
model of how surfactant functions to promote these biophysical properties is primarily
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based off evidence from in vitro studies using devices to visualize surfactant and measure
surface tension (see section 1.3.4). Importantly, no single component of surfactant is
efficient at achieving all three biophysical properties on its own (in vitro), indicating the
importance of cumulative effects of the various surfactant constituents.
The dominant phospholipid within surfactant is DPPC. Pure DPPC bilayers have a
relatively high melting temperature (42°C) promoting a gel-like membrane phase at
physiological temperatures (Possmayer et al., 2001). However, the addition of other bulkier
lipid components, such as unsaturated phospholipids and large amounts of cholesterol, to
DPPC membranes in vitro tends to lower the melting temperature of these membranes
closer to physiological temperatures (37°C) (Egberts et al., 1989). In turn, this promotes an
increase in the lateral mobility of phospholipids within these membranes, a factor referred
to as fluidity (Zuo et al., 2008). In vitro biophysical studies have generally shown that the
saturated components of surfactant are important for reducing surface tensions during
lateral compression, while the more fluidizing phospholipid species are thought to
contribute to adsorption, re-spreading, and monolayer to multilayer transition.

1.3.3.1- Rapid Adsorption
Adsorption is the process by which surfactant proteolipid complexes move from
the sub-phase to an interface, forming a surface film (Lopez-Rodriguez and Perez-Gil,
2014). As a result of surfactant movement to the interface, aqueous molecules at the surface
of the air-liquid interface are replaced with a film of phospholipids, reducing high surface
tensions of the aqueous molecules. If the adsorbing surfactant phospholipid is sufficiently
concentrated, the surface tension of pure water will be reduced from 70mN/m toward an
equilibrium tension of ~22-25mN/m (at 37°C), at which point phospholipids at the
monolayer are in equilibrium with molecules in the bulk of the hypophase. In vivo, this
process only occurs in the lungs at birth, after which the film is ever-present and
dynamically maintained. Thus, to study the adsorptive capacity of surfactant, in vitro
techniques using model surfactant preparations have been developed.
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In vitro, effective surfactant preparations are expected to adsorb to the air-liquid
interface within several seconds (Zuo et al., 2008; Lopez-Rodriguez and Perez-Gil, 2014).
Interestingly, biphasic phospholipid mixtures modelling the lipid components of surfactant
(DPPC and unsaturated PC or PG) do not possess the ability to rapidly reduce surface
tension at the air-liquid interface upon deposition within the sub-phase in vitro. However,
the addition of hydrophobic surfactant proteins, SPB and SPC to these biphasic
phospholipid mixtures, immediately improves the rate of adsorption (OosterlakenDijksterhuis et al., 1991b; Nag et al., 1999; Rodriguez-Capote et al., 2001). Furthermore,
in the presence of SPB, SPA has been shown to enhance phospholipid adsorption in vitro
(Schürch et al. 1992; Yu and Possmayer, 1996; Rodriguez-Capote et al., 2001). It should
be noted that SPA is not absolutely required for surfactant biophysical function as indicated
by SPA knockout animals which have phenotypically normal lung physiology (Korfhagen
et al., 1998). Based on these in vitro findings, it is thought that these hydrophobic surfactant
proteins help to facilitate the transfer of surfactant from the multilayer surfactant reservoir
into the interfacial film (Perez-Gil and Weaver, 2010). Finally, it should be noted that the
addition of fluidizing lipids to DPPC mixtures may also promote the rate at which
surfactant may adsorb to the interface compared to pure DPPC in vitro (Walters et al.,
2001). However, the role of these fluid lipid components in this process appears to be
relatively minor compared to the role of surfactant proteins (Holm et al., 1996; Diemel et
al., 2002).

1.3.3.2 - Low Surface Tension upon Lateral Compression
The most physiologically important biophysical property of surfactant in vivo is the
ability to reduce surface tensions to near 0mN/m values upon expiration, allowing the
stabilization of the alveolus (see LaPlace’s Law). Achievement of low surface tension upon
compression in vivo is a continuous process that occurs upon every exhalation of the
respiration cycle. In a competent surfactant, compressions of about 20-30 % surface area
reduction should be enough to produce a stable, a near zero minimum surface tensions
(Schürch et al., 1976), corresponding to the changes in alveolar surface area that occur
during resting ventilation (Bachofen and Schürch, 2001). Although very low surface
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tension have been measured within the lung, the models explaining how low surface
tension is achieved has predominately been based on in vitro experiments involving
compression and expansion of phospholipid bilayer and monolayers.
In vitro studies compressing monolayers of surfactant phospholipids have
concluded that surfactant surface films composed of DPPC and other saturated
phospholipids are predominately responsible for the near 0 mN/m surface tensions
achieved in the lung (Notter and Morrow, 1975; Hawco et al., 1981). Compression of other
bulkier unsaturated surfactant PC films are generally unable to achieve low surface
tensions of the same magnitude (Notter and Morrow, 1975; Possmayer et al., 2001). This
phenomenon is explained by the ability for DPPC molecules to be tightly compressed
together with little interference from neighbouring saturated acyl tails, forming highly
packed membranes at the interface. Alternatively, phospholipid membranes composed of
unsaturated lipids or the addition of high levels of cholesterol to a phospholipid membrane
prevents as close of an association to neighbouring phospholipids resulting in more fluid
membranes, which cannot pack tightly to reduce surface tension to the same extent when
compressed as a monolayer.
The alveolar surface is constantly exposed to compression and expansion. To
stabilize the alveolar surface during low lung volumes, low surface tensions must be
achieved. Given that surfactant phospholipid films are typically composed of 30-60%
DPPC and considerable quantities of other fluidizing unsaturated phospholipids and
cholesterol, in order to reach near zero surface tensions, it is believed the surface film must
be remodelled during compression (Figure 1.4). It is currently theorized that during
interfacial compression as would occur during respiration, there is a progressive refinement
of the interfacial surface, such that more fluid lipid components such as unsaturated
phospholipids and cholesterol are squeezed out from the interfacial surface (Perez-Gil and
Weaver, 2010; Lopez-Rodriguez and Perez-Gil, 2014; Baoukina et al., 2014). This type of
lipid refinement would favour DPPC enrichment at the interface, resulting in a tightly
packed surface membrane capable of achieving surface tensions near 0 mN/m (Figure
1.4A). Several other studies have suggested SPB and SPC help to refine the surface film
during instances of lateral compression (Diemel et al., 2002; Nag et al., 1999; Leonenko et
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al., 2007; Lee, 2008; Lopez-Rodriguez and Perez-Gil, 2014). Despite refinement of
surfactant at the air-liquid interface during compression, highly fluidized membranes may
also impair the ability of the surfactant to achieve low surface tensions during compression.
For example, in vitro studies by Hawco et al., demonstrated that addition of unsaturated
phospholipids in high proportions to DPPC monolayers impaired their ability to reduce to
low surface tension upon compression with a Langmuir balance. Furthermore, as the
proportion of these unsaturated lipids increased within the surfactant membrane, so did the
minimum surface tensions achieved of the lipid monolayers (Hawco et al., 1981). Similar
studies have demonstrated similar findings with the addition of ~10-20% cholesterol
(Gunasekara et al., 2005; Notter et al., 1980). It has been suggested that these bulky
fluidizing molecules impair the ability to achieve an enriched DPPC membrane upon
compression.
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Figure 1.4 – Surfactant interfacial films during compression and expansion of the interface.
(A) Compression of the interfacial film is believed to promote exclusion of more fluid
components of surfactant (unsaturated phospholipids and cholesterol) into the bilayer
phases below the interfacial film. This produces an enrichment of DPPC molecules at the
interface, resulting in low surface tension (~0mN/m). (B) During expansion of the
interfacial film, material from the surfactant reservoir in the multilayer is re-adsorbed into
the interfacial film. Note: the hydrophobic proteins SPB/C play a major role in these
processes, however, are not shown in this figure for simplicity.

1.3.3.3 - Efficient Re-spreading
Low surface tensions reflect the ability of surfactant to stabilize the lung during
exhalation. Conversely, during lung re-expansion or inhalation, the surface area of the airliquid interface increases and surfactant from the multilayer reservoir below must be reinserted at the interfacial film to prevent high surface tensions of the expanding aqueous
hypophase (Figure 1.4B). In a healthy lung in vivo, it is expected that surface tensions
achieved during re-expansion would not exceed equilibrium surface tension of ~22-
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25mN/m (Schurch et al., 1978; Zuo et al., 2008) reflecting efficient re-insertion of surface
active surfactant back into the surface. Although in vitro maximum surface tensions beyond
equilibrium values may be sustained due to differences in the environment at which
surfactant is exposed, maximum surface tension is a good indicator of the efficiency at
which surfactant is re-incorporated into the expanding interface in experimental samples
(Diemel et al., 2002; Baumgart et al., 2010). In regards to re-spreading, it is the unsaturated
phospholipids and cholesterol within surfactant lipids that are thought to be important for
re-incorporation into the surface film (Notter et al., 1980; Taneva and Keough, 1997). For
example, compressing binary mixtures of DPPC with physiological levels of unsaturated
PC (1:1) or cholesterol (9:1), promoted significantly enhanced re-spreading of material to
the interface as compared to DPPC alone (Notter et al., 1980). SPB and SPC additionally
play an important role in facilitating the re-spreading of phospholipids upon changes in
alveolar surface area (Baumgart et al., 2010), likely by aiding and stabilizing the transfer
of surfactant from the reservoir to the interface (Lopez-Rodriguez and Perez-Gil, 2014).

1.3.4 - Experimental Assessment of Surfactant Biophysical Function
Surfactant is able to rapidly adsorb to the air-liquid interface, reach very low surface
tension upon film compression, and re-insert back into the surface layer at the air-liquid
interface during film expansion, completing one dynamic compression-expansion cycle. In
vivo, it is difficult to study the surface tension reducing properties of surfactants produced
endogenously within the host. The majority of methods used to study surfactant biophysical
function in vivo involve removal or administration of surfactant from the lungs and
observing the subsequent impact on gas exchange or pulmonary compliance rather than
precise measurements of surface tension achieved in the lung (Zuo et al., 2008). Although
certain techniques (microdroplet technique) have been used to directly study surface
tensions in situ within lung (Schürch et al., 1976), these methods are fairly inconvenient.
As such, methods to study surfactant function, and measure surface tension reduction have
been made simpler and more direct using in vitro techniques, by means of instruments such
as Langmuir balances and surfactometers. These devices can replicate the dynamic surface
area behaviour of the alveolar hypophase during respiration, allowing for accurate
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assessment of surface tension in isolated surfactant films outside of the lung during
instances of lateral compression and relaxation.

1.3.4.1 - The Constrained Sessile Drop Surfactometer (CSD)
In vitro analysis of surfactant biophysical function may be assessed through the use
of a variety of surfactometers, each with their own specific set of advantages and
disadvantages (Zuo et al., 2008). To assess isolated surfactant biophysical function in this
thesis, a constrained sessile drop surfactometer (CSD) was used (Figure 1.4). The CSD was
first developed by Wulf and colleagues to measure the surface tension of polymer melts,
and was later modified by Yu and associates to allow for the application of isolated
surfactant surface tension assessment (Wulf et al. 1999; Yu et al., 2004). The CSD is an
ideal surfactometer for assessment of surfactant biophysical function because of i) the
environmentally controlled chamber allowing the experimenter to mimic lung temperature
and humidity, ii) the requirement for low surfactant sample volumes (~10uL per replicate),
and iii) a razor shape edge on the pedestal preventing surfactant sample leakage, which was
common in other surfactometers (Yu et al., 2004). Furthermore, the CSD presents with
very few disadvantages within the context of surfactant biophysical assessment (Zuo et al.,
2008).
Surfactant adsorption, surface tension reduction upon compression, and respreading capabilities may all be assessed on the CSD. The CSD consists of a metal
pedestal within an environmentally controlled chamber set at 37°C, connected to a syringe
filled with water (representing the alveolar hypophase) via tubing (Fig 1.4A). To begin
biophysical assessment, a small volume (~9-10µL) of surfactant sample is deposited on top
of the CSD pedestal. The surfactant sample is allowed to equilibrate over several minutes
to determine the surface tension during adsorption. To model the respiratory cycle and
assess change to surface tension during changes in surface area, the surfactant sample is
exposed to dynamic compression-expansion cycles (Fig 1.4B). This is done by exchanging
fluid from the surfactant sample drop and the loaded CSD syringe. Within the centre of the
pedestal, there is a 1mm pinhole directly in contact with the water filled syringe. The piston
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within the syringe may be withdrawn or advanced using a custom designed software (‘The
Dropper’) and a computer controlled stepper motor to influence the volume and surface
area of the surfactant sample on the pedestal, causing surfactant to compress and expand,
respectively. Along the horizontal plane of the pedestal is a monochromatic light source
and a microscopic camera, used for capturing images of the illuminated CSD pedestal and
sample. During biophysical assessment, images are recorded and later analyzed for
surfactant surface tension measurements in conjunction with software Axisymmetric Drop
Shape Analysis (ADSA) (Kalantarian et al., 2011). Thus, the CSD allows for in vitro
assessment surface tension during adsorption and dynamic cycling.

22

Figure 1.4 – A schematic of the constrained sessile drop surfactometer (A). Surfactant
samples are placed on the surfactant pedestal forming a sessile drop. The volume of the
drop is increased and decreased, laterally expanding and compressing the drop respectively
(B). Images are rapidly recorded with a microscopic camera for later analysis with ADSA
– axisymmetric drop shape analysis. γ= surface tension.
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1.3.3

– Clinical Significance of Surfactant
The importance of surfactant membrane secretion, maintenance, and biophysical

function toward normal respiratory mechanics and aeration of the lung is best illustrated
by clinical examples of patients afflicted by neonatal respiratory distress syndrome (RDS),
or acute respiratory distress syndrome (ARDS).
RDS is characterized by underdevelopment of the lungs; newborns affected exhibit
increased work of breathing, lower pulmonary compliance, collapsed alveoli, and impaired
gas exchange. In 1959, Avery and Mead discovered that lung extracts isolated from infants
that died of RDS had impaired surfactant surface tension reduction, compared to the lung
extracts of infants who died of non-pulmonary related disorders (Avery and Mead, 1959).
These findings and subsequent studies would later establish that surfactant deficiency and
associated dysfunction was responsible for the poor respiratory function of those afflicted
by RDS (Farrell and Avery, 1975; Reynolds et al., 1968). Today, RDS is less of clinical
concern due to advances in surfactant replacement therapy used to treat the lungs of
premature infants. Instillation of a single dose of exogenous surfactant preparations in the
trachea of an RDS neonate counteracts surfactant insufficiency and increases arterial
oxygenation and overall survival (Fugiwara et al., 1980; Smyth et al., 1983; Enhorning et
al., 1985). The impact of surfactant deficiency on lung function and subsequent reversal
using adequate instillation of exogenous surfactant formulations clearly demonstrates the
importance of surfactant within alveolar airspaces toward healthy respiratory function.
ARDS, a disease of the mature lung, is defined by acute lung inflammation and
increased pulmonary vascular permeability, preventing aeration of lung tissue. Similar to
RDS, surfactants isolated from ARDS patients have impaired function; however it is
qualitative biochemical and biophysical surfactant abnormalities which contribute to
respiratory failure, rather than sheer surfactant deficiency (Günther et al., 2001).
Unfortunately, despite improving patient oxygenation, surfactant replacement therapy has
largely been unsuccessful regarding the improvement of patient mortality within the
context of ARDS (Günther et al., 2001; Dushianthan et al., 2012). As will become apparent,
surfactant alterations during ARDS clearly demonstrate that the precise balance of
surfactant constituents is crucial for normal surfactant biophysical function within the lung.
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1.4

Acute Respiratory Distress Syndrome and Mechanical Ventilation
1.4.1 – Acute Respiratory Distress Syndrome
ARDS is a pulmonary disorder caused by direct (e.g. trauma or acid aspiration) or

indirect (e.g. sepsis or inflammation) pulmonary insults promoting impaired aeration of
alveolar tissue. These insults lead to the hallmark characteristic of reduced partial pressure
of arterial blood oxygen (Ware and Matthay, 2000). In addition to hypoxemia, ARDS
patients also present with bilateral lung infiltrates, and decreased pulmonary compliance.
ARDS is sub-classified according to the severity of hypoxemia and ranges from mild
ARDS (PaO2: FiO2<300) to severe ARDS (PaO2: FiO2<100) (Ranieri et al., 2012).
The potential causes of ARDS include many noxious insults to the lung, each of
which may lead to different intracellular alterations in the lung, making this disorder
particularly difficult to treat. Unfortunately, no effective pharmacotherapy currently exists
which benefits all patients afflicted by ARDS (Bosma et al., 2010; Del Sorbo et al., 2011).
This lapse in effective ARDS patient therapy is reflected by a relatively unchanged
mortality of 30-40% (Ware and Matthay, 2000; Phua et al., 2009). Due to the inadequate
oxygenation of patients diagnosed with ARDS, supportive mechanical ventilation is used
as an essential therapeutic intervention. Mechanical ventilation is the artificial inflation and
deflation of the lung to facilitate gas exchange and represents the standard of care for
patients with ARDS. However, mechanical ventilation of the pre-injured lung may
exacerbate pulmonary injury through several mechanisms.

1.4.2 – Injurious Mechanical Forces on the Lung
Although mechanical ventilation is the primary supportive therapy to ARDS
patients, it represents a significant risk toward the development of more severe lung injury.
In general, two factors influence the progression of lung injury during mechanical
ventilation: 1) alveolar over-distension, and 2) repeated alveolar recruitment and derecruitment (Tremblay and Slutsky, 2006). Over-distension occurs during inhalation when
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excessive VTs flow into the lung, causing deformation of alveolar tissue (Dreyfuss and
Saumon, 1998; Dreyfuss et al., 1988). Conversely, alveolar de-recruitment occurs when
pressure remaining in the lung at the end of expiration (also called positive end-expiratory
pressure, or PEEP) is inadequate to prevent collapse of the alveolus, and subsequent reopening of the collapsed alveolus during the next inhalation cycle produces shear stress on
the alveolar tissue (Del Sorbo et al., 2011).

1.4.3 – Mechanical Ventilation of ARDS Patients.
Mechanical ventilation represents a large risk to ARDS patients; however certain
levels of VT and PEEP have been directly related to the generation of excessive forces on
alveolar tissue during mechanical ventilation. Traditionally, patients afflicted with ARDS
were ventilated with large VTs (10-15mL/kg) exceeding normal resting VTs (~6-7mL/kg)
in efforts to promote increased arterial oxygenation and prevent high arterial PaCO2. Very
little change in the way ARDS patients are ventilated was established until the results of a
large multi-centered trial by the ARDS Network were published in 2000. This seminal
study demonstrated that ARDS patients ventilated with low tidal volumes of 6mL/kg and
plateau pressure restriction had significantly lower mortality (22%) and increased number
of ventilator-free days as compared to patients ventilated with traditional tidal volumes of
10-12ml/kg (ARDSnet, 2000). Thus, it was recommended that clinicians provide lung
protective ventilation strategies using low VT in ARDS patients to improve overall patient
survivability and minimize the risk of injury incurred on the ventilator.
In addition to reducing VT during ventilation, there is a multitude of evidence from
animal models to suggest maintaining small amounts of pressure in the lung at the end of
expiration (PEEP) during mechanical ventilation is protective against alveolar collapse and
the development of lung injury, edema, and surfactant alterations that may occur when
PEEP is absent (Dreyfuss et al., 1988; Webb and Tierney, 1974; Verbrugge et al., 1998;
Tremblay and Slutsky, 2006). Although these models have inferred that the higher levels
of PEEP may protect from the development of lung injury, trials in human ARDS
populations on the mechanical ventilator have led to inconsistent results (Dasenbrook et al.
2011). For example, in a follow-up study to the ARDSnet study in 2000, it was found that
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mechanical ventilation of ARDS patients with lower levels of PEEP (8cmH2O) compared
to higher levels (13cmH2O) had no beneficial impact on mortality when patients were
ventilated with a given tidal volume (ARDSnet, 2004). It is now suggested that extent of
PEEP applied to the lung during mechanical ventilation of ARDS patients should be
tailored according to the trans-pulmonary pressure and the individual’s lung mechanics
(Fan et al., 2013).
Although these large trials have demonstrated that lung protective ventilation
strategies should be applied to ARDS patients, there is still a risk for the development of
lung injury. Ventilation of the pre-injured lung with physiologically relevant VTs (67mL/kg) may result in regional areas of alveolar over-distension (Tremblay and Slutsky,
2006). For example, in localized areas of injury where the alveoli have collapsed or been
flooded with proteinaceous edema (i.e. in ARDS patients), physiological VTs are unevenly
distributed to healthy regions of the lung, exposing some alveoli to relatively large VTs
(Gattinoni et al., 1986). Furthermore, pre-existing surfactant impairments that may have
occurred during ARDS may result in increased susceptibility to alveolar collapse (Taskar
et al., 1997), and may promote exertion of a large force on lung tissue during inhalation.
Thus within clinical practice, lung injury may be incurred during protective mechanical
ventilation of the injured lung.

1.4.4 – Ventilation Induced Lung Injury
It is difficult to discern between injury induced by the ventilator and that of the
underlying disease for which mechanical ventilation was initiated due to the similar
pathological manifestations of the respiratory system (Fan et al., 2013; Tremblay and
Slutsky, 2006). Thus, in order to study the damaging effects of mechanical ventilation in
isolation, animal models employing high VTs and 0 cmH2O PEEP (ZEEP) have been
developed in which the injury is called ventilation induced lung injury (VILI) (Dreyfuss
and Saumon, 1998). In these models, the use of large VTs (>20mL/Kg) promotes excessive
alveolar distension, while ZEEP ensures an inadequate pressure upon the end of expiration,
promoting alveolar de-recruitment and collapse. These models have promoted similar
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physiological findings to patients diagnosed with ARDS and exposed to mechanical
ventilation, producing changes to the lung such as protein edema, loss of arterial
oxygenation, and altered surfactant composition and function (Webb and Tierney, 1974;
Dreyfuss et al., 1988; Dreyfuss and Saumon, 1998; Veldhuizen et al., 2000; Veldhuizen et
al., 2002; Tremblay and Slutsky, 2006).
The above observations indicate how parameters set by the respirator (VT, PEEP)
during mechanical ventilation may impact the development of injury and subsequent
mortality. Considering the requirement for mechanical ventilation in ARDS patients, and
the deleterious physiological effects that may occur as a result of ventilation of the preinjured lung, it is important to understand how mechanical ventilation may contribute to
the propagation of lung injury.

1.4.5 – Surfactant Alterations during VILI
It has been shown mechanical ventilation further contributes to alterations and
impairments of the endogenous surfactant system resulting in worsening of lung
mechanics. Preliminary studies conducted by Greenfield and co-workers initially reported
alterations to surfactant function following mechanical ventilation of dog lungs. In this
study, lung extracts isolated from dogs ventilated for 2 hours with large inspiratory
pressures and tidal volumes, demonstrated significant impairment in surface tension
reduction compared to dogs ventilated with physiological tidal volumes when surfactants
were compressed on a Wilhelmy balance (Greenfield et al., 1964). Later, in 1974 Webb
and Tierney postulated that surfactant dysfunction associated with certain ventilation
strategies likely contributed to the progression of lung injury due to alveolar instability
(Webb and Tierney, 1974; Tremblay and Slutsky, 2006). Studies have since shed light on
the role of surfactant dysfunction in the progression of VILI (Verbrugge et al., 1998;
Veldhuizen et al., 1996; Veldhuizen et al., 2000; Veldhuizen et al., 2002; Panda et al.,
2004; Maruscak et al., 2008; Vockeroth et al., 2010). While these studies have
demonstrated the adverse alterations to surfactant that occur upon secretion into the
alveolar hypophase, there have been very few investigations into the impact of ARDS or
mechanical ventilation on intracellular surfactants, such as lamellar bodies. As such, the
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intracellular impact of alveolar over distension and repeated collapse induced by VILI on
surfactant prior to secretion into the airspace remains unknown and will represent a primary
focus of a study in this thesis.
Changes to extracellular surfactant have been well-characterized in the lungs of
animals exposed to VILI induced through ventilation with high VT and lack of PEEP.
These alterations are I) increased conversion of surfactant large aggregates to biophysically
inactive small aggregates (Veldhuizen et al., 1996; Ito et al., 1997; Verbrugge et al., 1998;
Malloy et al., 2000) II) reduced expression of SPA, SPB, and SPC (Veldhuizen et al., 2000)
and III) serum protein leakage into the airspaces interfering with surfactant formation at
the air – liquid interface (Veldhuizen et al., 1996; Verbrugge et al., 1998; Malloy et al.,
2000; Gunther et al., 2001).
For example, in a rabbit model of VILI using high VT (13-15mL/kg), increased
large aggregate surfactant conversion to its biophysically inactive small aggregates was
observed compared to rabbits ventilated with low VTs (Veldhuizen et al., 1996). The
increased conversion has been demonstrated to be dependent on large changes in alveolar
surface area associated with the ventilation strategy (Ito et al., 1997; Gunther et al., 1999).
Furthermore, it has been demonstrated that increased conversion of the large aggregate
fraction to small aggregates is associated with impairments in surfactant surface tension
reduction in vitro (Gunther et al., 1999).
More recently it has been demonstrated that high levels of cholesterol in surfactant
films impair its overall biophysical function. Furthermore, increases in cholesterol
recovered in surfactant has been described within the context of lung injury induced by
VILI (Panda et al., 2004; Maruscak et al., 2008) suggesting that this type of surfactant
modification may represent an important mediator of surfactant dysfunction.

1.4.6. Elevated Surfactant Cholesterol
Within the past ten years, there has been a growing amount of evidence to suggest
that elevated levels of cholesterol beyond normal physiological levels found in surfactant
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films (>4-10% phospholipid) are detrimental to its biophysical function in vitro. These in
vitro studies using exogenous surfactant preparations, such as bovine lipid extract
surfactant (BLES) composed of phospholipids and hydrophobic surfactant proteins, have
demonstrated adding cholesterol to levels of 10-20% phospholipids (20-40 mol%) alters
surfactant such that adsorption, reversible monolayer to multilayer transition, and surface
tension reduction during compression are all significantly impaired (Saad et al., 2009;
Gunasekara et al., 2008; Gunasekara et al., 2005; Leonenko et al., 2007; Keating et al.,
2007).
Elevated levels of cholesterol in surfactant may also represent a mechanism by
which surfactant may become impaired in vivo. For example, a previous study conducted
in our lab has demonstrated surfactant isolated via lung lavage of VILI exposed rats injured
with high VTs (30mL/kg) and ZEEP, had significantly elevated levels of cholesterol
associated with surfactant (~13% phospholipid) compared to non-injurious ventilation
(~8% phospholipid) (Maruscak et al., 2008). In a follow-up study using the same model of
lung injury, it was demonstrated these high quantities of surfactant cholesterol contribute,
in part, to the impairments in surfactant surface tension reduction isolated from VILI
injured animals (Vockeroth et al., 2010). When surfactant isolated from rats exposed to
VILI had free cholesterol removed via chemical sequestration with methyl-betacyclodextrin (MβCD), a significant restoration toward the achievement of low surface
tension was observed. Furthermore, re-adding cholesterol back to original quantities
measured restored the naive biophysical impairment of crude surfactant films (Vockeroth
et al., 2010). Together, these studies concluded that this type of surfactant alteration is
relevant toward the progression of lung injury in VILI exposed animals.
These experiments were performed in experimental rat models of VILI and as such,
it is unknown whether supra-physiological levels of cholesterol represent a broad marker
of surfactant inactivation in ARDS or whether these changes are unique to the pathological
consequences of VILI. However, several studies have indicated high levels of cholesterol
in surfactant may play a role in lung injury in human patients on the mechanical ventilator.
For example, ARDS patients receiving supportive mechanical ventilation demonstrated
higher levels of cholesterol and other neutral lipids within surfactant large aggregates
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recovered by lavage compared to healthy control subjects (Markart et al., 2007).
Furthermore, in a separate study by Qua Hiansen and colleagues, surfactant isolated by
lavage from patients undergoing long-term mechanical ventilation for the treatment of
major trauma had significantly improved surface tension reduction when surfactant was
co-administered with cholesterol sequestering agent MβCD (Qua Hiansen et al., 2015).
The results of these studies in humans have suggested that high levels of cholesterol in
surfactant may be relevant to mechanical ventilation of patients with ARDS. However,
future studies are required to confirm such speculations.
Cholesterol is a natural component of surfactant, which may become elevated
following exposure to injurious mechanical ventilation. However, at this time it remains
unknown precisely how surfactant cholesterol levels may become augmented in response
to VILI or mechanical ventilation. Because the majority of surfactant cholesterol is
incorporated from the serum, one possibility is that increased cholesterol substrate may
favour increased incorporation into surfactant membranes (McCrae et al., 2008).
Furthermore, since the majority of surfactant cholesterol is first incorporated into surfactant
during lamellar body production (Hass and Longmore, 1979), it is worthwhile to see how
VILI impacts intracellular incorporation of cholesterol into surfactant.

1.5 – Rationale and Hypotheses
The ability of the lungs to successfully facilitate gas exchange is highly dependent
on the proper biophysical properties of surfactant. During ARDS, alveolar gas exchange
becomes highly impaired and patients require mechanical ventilation. Unfortunately,
mechanical ventilation may promote lung injury, causing broad alterations to the
pulmonary surfactant system which exacerbate pre-existing lung injury. Recent
investigations regarding cholesterol content in extracellular surfactant has led to the
conclusions that high surfactant cholesterol represents a distinct mechanism by which
surfactant becomes biophysically inactivated in animal models of VILI.
The objective of this thesis is to provide insight into the biophysical impairments
associated with surfactant in the lung following exposure to ARDS and mechanical
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ventilation.

To complete this objective, two related, but independent studies were

performed in rats. Firstly, the impact of serum hypercholesterolemia and its downstream
consequences on alveolar surfactant cholesterol levels and their contribution toward the
development of experimental ARDS and VILI was assessed. Secondly, a novel
investigation into the impact of VILI on lamellar body surfactant was undertaken to
determine if any surfactant alterations to composition and function may be mediated
intracellularly, prior to secretion into the airspaces.

1.5.1 – Objective 1 - Impact of Diet-Induced Serum Hypercholesterolemia
The first objective of this thesis aims at determining if serum hypercholesterolemia
is a major risk factor toward the dysfunction of surfactant biophysical function after
exposure to lung injury. Despite what is known regarding normal alveolar cholesterol
regulation and incorporation into surfactant, the physiological mechanism behind these
surfactant cholesterol increases induced over the course of injurious ventilation has yet to
be elucidated. Because ~99% of surfactant cholesterol originates from serum lipoproteins
(Hass and Longmore, 1979), it was investigated whether serum hypercholesterolemia
predisposed to increased cholesterol incorporation into surfactant, due to increased
availability. Serum cholesterol overload may potentially contribute toward impairments in
AIIE cholesterol handling by promoting the incorporation of cholesterol into surfactant
membranes, marring surface tension reduction, and contributing to more severe lung
injury.
Samples used in this biophysical study were obtained from a cohort of rats used in
a previously completed experiment investigating the physiological consequences and basic
compositional changes to surfactant induced by a high cholesterol diet following exposure
to various lung insults (Milos et al., 2016). It was hypothesized that rats fed a high
cholesterol diet would have impaired surfactant biophysical function compared to rats fed
a standard diet. Because this thesis investigates the biophysical function of previously
obtained samples, a brief discussion of this initial study and its results are presented below.
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Rats were exposed to a standard or acute high cholesterol diet for several weeks
and were randomized to receive one of three experimental models of ARDS and associated
controls: VILI, acid aspiration, and surfactant depletion. All animals were ventilated
following experimental treatment or injury, and lung physiology (arterial oxygenation and
peak inspiratory pressure [PIP] - Table 1.1) was assessed to determine whether the diet
produced an increased susceptibility to a more severity lung injury. Following ventilation,
surfactant was collected by lavage for basic compositional and pool-size analysis (Table
1.2) to determine any impact diet-induced serum hypercholesterolemia may have had.
The physiological impact of a high cholesterol diet on the severity of lung injury is
shown in Table 1.1. Within all three separate injury models, there were significant changes
in arterial oxygenation and PIP following the initiation of mechanical ventilation as
compared to baseline (with the exception of the VILI – 2-hour groups). However, there
were no significant differences in any measured physiological outcomes between rats fed
either diet. These data conclude that although these experimental animal models induced
injury to the host, serum hypercholesterolemia was not a risk factor for the development of
more severe lung injury outcomes.
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Table 1.1 – Lung physiology of standard and high cholesterol diet fed rats exposed to 3
experimental models of ARDS and associated controls.

Time

PaO2:FiO2 (mmHg)
Standard

HCD

PIP (cmH2O)
Standard

HCD

Control Ventilation – 2 hours
Baseline

448.8±13.0

486.7±20.1

10.2±0.3

10.1±0.3

120
minutes

466.7±17.1

471.8±16.9

13.5±0.5

13.2±0.6

VILI – 2 hours
Baseline

466.7±15.7

472.4±13.2

22.5±2.1

23.7±1.4

120
minutes

459.0±22.3

392.0±35.4

25.9±0.6

26.6±1.6

VILI – 3 hours
Baseline

454.3±30.5

482.0±11.3

11.3±0.4

10.6±0.5

180
minutes

200.5±121.6§

222.5±82.7§

31.8±2.9§

31.4±2.2§

Air Aspiration + 2 hours MV
Baseline

482.7±21.7

476.0±32.4

11.4±0.4

11.0±0.2

120
minutes

501.3±12.6

503.0±22.2

14.2±0.5§

14.1±0.8§

Acid Aspiration + 2 hours MV
Baseline

456.6±20.0

482.3±24.7

11.2±0.4

11.7±0.5

120
minutes

306.411#§

345.4±54.3#§

17.4±0.5#§

18.6±1.6#§

Surfactant Depletion + 2 hours MV
Baseline

449.4±18.6

499.0±9.5

11.0±0.3

11/0±0.4

120
247.7±61.6§ 221.6±48.7§
19.3±1.2§
20.4±1.6§
minutes
# indicates P<0.05 - acid vs air aspiration within diet. § indicates P<0.05 - baseline vs end
of ventilation within diet. n=4-9/treatment group. MV – mechanical ventilation
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Analysis of extracellular surfactant phospholipid pools and cholesterol content
isolated from rats via lung lavage exposed to the three models of injury are shown in Table
1.2. Overall within each of the three models of ARDS, there were no significant differences
in the amount of recovered total surfactant or surfactant large aggregates between rats fed
the two diets, concluding that this type of diet did not affect surfactant pool sizes.
Furthermore, there was no difference in the amount of cholesterol measured within large
aggregates between the two diets within any experimental model. Only rats exposed to
VILI for 3 hours had a statistically significant increase (P<0.05) in surfactant cholesterol
levels beyond those of naïve animals (data not shown).
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Table 1.2 –Surfactant composition isolated from rats fed a standard and high cholesterol
diet and exposed to 3 experimental models of ARDS and associated controls

Diet

Standard
High
Cholesterol
Standard
High
Cholesterol

Standard
High
Cholesterol

Standard
High
Cholesterol
Standard
High
Cholesterol

Standard
High
Cholesterol

Total
Surfactant
(mg/kg BW)

Large
Aggregates
(mg/kg BW)

Cholesterol
(%Large
Aggregate)

Control Ventilation – 2 Hours
4.63 ± 0.45
3.03 ± 0.30

7.06 ± 0.40

5.09 ± 0.31

2.90 ± 0.32

7.60 ± 1.09

VILI– 2 Hours
7.92 ± 0.63
3.73 ± 0.35

5.90 ± 0.69

7.78 ± 1.74

6.99 ± 0.69

3.08 ± 0.97

VILI– 3 Hours
6.37 ± 0.92
3.27 ± 0.56

10.45 ± 1.26*

6.24 ± 0.87

11.98 ± 0.67*

2.06 ± 0.15

Air Aspiration + 2 Hours MV
4.81 ± 0.81
2.69 ± 0.35

5.00 ± 0.40

4.29 ± 0.38

6.18 ± 0.52

2.58 ± 0.25

Acid Aspiration + 2 Hours MV
5.56 ± 0.61
3.10 ± 0.33

5.52 ± 0.28

4.77 ± 0.42

6.06 ± 0.56

2.73 ± 0.31

Surfactant Depletion + 2 Hours MV
3.06 ± 0.37
1.67 ± 0.23
4.49 ±1.21
3.61 ± 0.43

1.41 ± 0.21

6.30 ± 0.67

* indicates P<0.05, VILI- 3 hours vs. naïve, non-ventilated rat (data not shown), n=49/group
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Despite the absence of differences between diets in regards to rat lung physiology,
surfactant pool size, and surfactant cholesterol content, analysis comparing surfactant
biophysical function in these samples had not yet been assessed. Therefore in this thesis,
the general in vivo contribution of a high cholesterol diet toward surfactant biophysical
function and surface tension reduction in vitro was investigated.

Note: these studies involving pulmonary physiology, surfactant composition, and
surfactant biophysical function discussed in the coming chapters, have been consolidated
and published as Milos et al., 2016.

1.5.2 –Objective 2 - Impact of VILI on Lamellar Body Surfactant
The second objective of this thesis focused on biophysical alterations to
intracellular lamellar body surfactant following exposure to VILI induced by high VT and
ZEEP. There have been extensive investigations into biophysical impairments of
extracellular surfactant isolated from lavage following VILI, however it is unknown to
what extent biophysical function of surfactant is impaired during intracellular lamellar
body synthesis and production within AIIE in response to this type of injury. The
understanding into how surfactant impairments are mediated in response to VILI may help
to address the negative impact of ventilation in ARDS patients. It was hypothesized that
VILI would promote significant alterations to lamellar body phospholipid recovery,
composition, and biophysical function compared to those isolated from ventilation
controls.
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Chapter 2 –Methods
To assess the role of VILI on isolated surfactant biophysical function in this thesis,
two independent experiments were performed. In the first experiment, extracellular
surfactant was isolated from injured rats fed either a standard or high cholesterol diet to
determine the impact of a serum hypercholesterolemia on surfactant biophysical function
in vitro. Since these samples were obtained from a previous study (Milos et al., 2016), the
initially obtained data that is relevant to this thesis is shown in Tables 1.1 and 1.2.
Furthermore, a brief description of the methodology used to isolate the samples is
presented. In the second experiment, lamellar bodies were isolated from mechanically
ventilated rats to determine the impact of VILI on intracellular surfactant’s basic
composition and biophysical function in vitro.

2.1 Experimental Designs
2.1.1 – Impact of Diet-Induced Serum Hypercholesterolemia
Samples used to assess the impact of a high cholesterol diet on surfactant
biophysical function were obtained from a previous experiment. A schematic of the
experimental design used in this study is shown in Figure 2.1. In this study, six week old
male Sprague-Dawley rats (Charles River, St. Constant, PQ, CAN) were randomized to
receive an acute diet of standard chow (~0% cholesterol and cholic acid) or a high
cholesterol diet (1.25% cholesterol and 0.5% cholic acid, by mass). Rats were fed these
diets for the next 17-20 days, after which serum cholesterol levels were measured.
Upon diet completion, it was observed that rats fed a high cholesterol diet had a
significant elevation in serum cholesterol levels (8.57±0.6mM) compared to rats fed a
standard diet (1.94±0.1mM), P<0.05, n=8-13/diet. Rats (weighing 340-425g) were
subsequently grouped into one of three experimental models of ARDS and their respective
controls described below: VILI or control ventilation (CV), acid or air –aspiration control,
and surfactant depletion (n=4-9/group). Once assigned to a group, each rat was prepared
for mechanical ventilation.
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Figure 2.1 – Experimental design of the first study investigating the impact of a high
cholesterol diet on extracellular surfactant biophysical function following exposure to three
independent models of lung injury. Surfactant was assessed in vitro on the constrained
sessile drop surfactometer (CSD). * indicates the additional use of 180 minutes of
mechanical ventilation.

2.1.2 – Impact of VILI on Lamellar Body Surfactant
An overview of the experimental design investigating the role of VILI on lamellar
body composition and biophysical function is presented in Figure 2.2. Male SpragueDawley rats age 6 to 10 weeks old and weighing 300-550g were used for this experiment.
Rats were acclimatized to the housing facility for at least 72 hours prior to experimentation
and were allowed food and water ad libitum. Rats were then randomized to one of three
groups (n=6-8) within the experimental model of VILI: non-ventilated controls (NV),
control ventilation (CV), and ventilation induced lung injury (VILI). CV and VILI animals
were prepared for mechanical ventilation, while NV animals were not ventilated and were
immediately prepared for isolation of lamellar bodies. A separate cohort of NV rats (n=3)
was used for the image analysis of isolated lamellar body via transmission electron
microscopy (TEM).
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Figure 2.2 – Experimental design of the second experiment investigating the impact of
VILI on isolated lamellar body composition and biophysical function assessed with the
constrained sessile drop surfactometer (CSD). A subset of non-ventilated animals had
lamellar bodies isolated for visualization via transmission electron microscopy (TEM).

2.2 – Surgical Procedures
All procedures were approved by the Animal Care Committee at the University of
Western Ontario in agreement with the Canadian Council of Animal Care.

2.2.1 – Ventilated Rats
For all experiments involving mechanical ventilation, rats were surgically prepared
for connection to a rodent ventilator as previously described (Aspros et al., 2010;
Vockeroth et al., 2010). Rats receiving mechanical ventilation were first anesthetized using
intraperitoneal injections of a ketamine (70-100 mg/kg) and dexmetatomidine or xylazine
(1 mg/kg, or 5 mg/kg respectively) mixed in sterile saline. Once successful anesthesia had
been achieved as indicated by a lack of toe-pinch response, rats were given subcutaneous
injections of analgesic buprenorphine (0.05-0.1 mg/kg) and local anesthetic bupivacaine
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(0.1- 0.25mL – 2.5%) at the intended site of incision. The ventral neck area was exposed
to allow for catheterization prior to placement on the ventilator. The left and right jugular
veins were exposed and catheterized to continuously deliver anesthetic (propofol - 0.5-2.0
mg/h), neuromuscular blocker (cisatracurium), and sterile fluids (heparinized saline). The
carotid artery was exposed and catheterized to allow for blood pressure, heart rate, and
blood gas measurements, and to allow continuous delivery of fluids (heparinized saline).
All fluids were delivered using infusion pumps (Model 22, Harvard Apparatus, St. Laurent,
PQ, CAN). Heparinized saline distributed to the veins and arteries was adjusted such that
total fluid received by the rat at any given time was 1 mL/100g/hr.
Following catheterization, the trachea of the rat was exposed and a 14-gauge
endotracheal tube was inserted and tightly secured. Rats were given a dose of
neuromuscular blocker, 100µg cisatracurium, and were simultaneously connected to a
volume cycled rodent ventilator (Model 683, Harvard Apparatus). Once animals were
placed on the rodent ventilator, they were ventilated with baseline settings: tidal volume
(VT) = 8mL/kg, respiratory rate (RR) = 54-58 beats/minute, positive end-expiratory
pressure (PEEP) = 5cmH2O, and fraction of inspired oxygen (FiO2) = 1.0. Animals were
given two breath holds (or sighs) to promote alveolar recruitment and were ventilated at
these settings for 15 minutes prior to sampling of baseline arterial blood gas. Rats were
further dosed with 100µg cisatracurium, administered every 15 minutes. The temperature
of rats over the course of mechanical ventilation was measured with a rectal thermometer
and temperature was maintained at 37 °C using heating pads. Blood gas measurements of
PaO2 and PaCO2 were assessed using a blood-gas analyzer (ABL 500, Radiometer,
Copenhagen, DK). Peak inspiratory pressure (PIP) was measured with a pressure monitor
(Model Criterion 40, Caradyne, Galway, IRE) connected to the rodent ventilator. To ensure
animals did not have pre-existing lung injury, inclusion criteria of arterial oxygenation
PaO2:FiO2 > 400mmHg was established.
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2.2.2 – Non-Ventilated Rats
NV animals were used within the lamellar body experiment only. Animals
randomized to NV did not undergo any of the above surgical preparations required for
mechanical ventilation and were instead euthanized immediately with an overdose of
sodium pentobarbital (110 mg/kg). Whole lungs were collected for isolation of lamellar
bodies (see section 2.4.2).

2.3 – Rats Models of Lung Injury
2.3.1 – Ventilation Induced Lung Injury
Both of the experiments described in this thesis utilized the same VILI model to
induce lung injury. Rats within each study were exposed to VILI or non-injurious CV.
Following baseline measurements, rats randomized to CV were ventilated without
alteration of the baseline ventilator settings (VT = 8mL/kg, RR=54-58bpm, PEEP =
5cmH2O, FiO2 = 1.0) for 120 or 180 minutes during which PIP, vital signs, and blood
oxygenation measurements were recorded every 15 to 30 minutes. Rats randomized to
receive VILI were transferred to a second rodent ventilator with a larger piston (Model
683, Harvard Apparatus) set to deliver an injurious ventilation strategy. The injurious
ventilator settings were as follows: VT = 25-30mL/kg, RR=15-18 bpm (beats per minute),
PEEP = 0cmH2O, FiO2 = 1.0. These rats were ventilated for 120 or 180 minutes and airway
pressure (PIP), vital signs, and blood oxygenation measurements were taken every 15 to
30 minutes.

2.3.2 – Acid Aspiration
Rats fed standard or high cholesterol diets assigned to the acid aspiration model of
lung injury followed a protocol similar to that of Aspros and colleagues (Aspros et al.,
2010). Following baseline measurements, animals were disconnected from the ventilator
and received an intratracheal dose of either 1M HCl (1 mL/kg) or a control air bolus (1
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mL/kg). Rats were ventilated for 120 minutes at baseline settings (VT=8mL/kg, RR=5458 bpm, PEEP= 5 cmH2O, FiO2 = 1) during which PIP, vital signs, and blood oxygenation
measurements were taken every 15 to 30 minutes.

2.3.3 – Surfactant Depletion
Rats fed a standard or high cholesterol diet randomized to the surfactant depletion
model of lung injury underwent procedures similar to those described previously (Bailey
et al., 2004). Briefly, rat lungs were repeatedly lavaged with aliquots of 10mL sterile saline
to remove the endogenous extracellular surfactant. After meeting the inclusion criteria of
PaO2:FiO2 < 250, animals were re-attached to the ventilator and ventilated at baseline
settings (VT=8mL/kg, RR=54-58 bpm, PEEP= 5 cmH2O, FiO2 = 1) for 120 minutes.
Airway pressure, vital signs, and blood oxygenation measurements were taken every 15 to
30 minutes.

2.4 - Surfactant Sample Collection
2.4.1 - Lavage Collection and Extracellular Surfactant Processing
Following the duration of ventilation (120 or 180 minutes), standard or high
cholesterol diet fed rats were euthanized with pentobarbital (110 mg/kg) via the left jugular
catheter and disconnected from the rodent ventilator. Whole lungs were lavaged five times
with 10mL of saline via a syringe connected to the endotracheal tube to isolate extracellular
surfactant. Each aliquot of 10mL of saline flushed the lung three times. Recovered lavage
fluid was pooled and spun at 150 x g to pellet cells and debris, separating them from
surfactant. Surfactant was spun at 40,000 x g to produce a pellet containing the large
aggregate sub-fraction (Veldhuizen et al., 1993) separate from small aggregates in the
supernatant. The large aggregate pellet was resuspended in saline and frozen at -4°C for
later analysis.
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2.4.2 Isolation of Lamellar Bodies
Following completion of 180 minutes of mechanical ventilation, rats were
euthanized with an overdose of sodium pentobarbital (110 mg/kg) via the left jugular
catheter and disconnected from the ventilator. Ventilated rats and NV rats had a midline
sternotomy performed, and isolation of lamellar bodies from whole lung tissue was
performed as described by Sanders and colleagues, with a few minor practical
modifications reported in similar studies (Gil and Reiss, 1973; Sanders et al., 1980;
Chander et al., 1986). The pulmonary circulation was perfused by flowing 10mL of icecold 0.32M sucrose solution from the inferior vena cava out a hole cut in the left ventricle
of the heart. All solutions used during experimentation were pre-cooled to 4°C, saline free,
contained 0.01M HEPES, and had a pH of 7.4. Lungs were excised out of the chest cavity
and briefly rinsed in 1.0M sucrose. Visible large airway tissue was removed from lungs
prior to weighing and tissue homogenization.
Lung tissue homogenization was carried out in steps. First, lungs were cut into
smaller pieces and chopped lengthwise, widthwise, and diagonally using a tissue chopper
(McIlwain Tissue Chopper, Mickle Laboratory Engineering Co. LTD, ENG) set to cut at
0.25 mm slice intervals. Next, tissue was added to 1.0M sucrose solution producing a 1020% (weight/volume) lung homogenate suspension. Homogenization was carried out using
five passes of a serrated, 0.15-0.23 mm clearance pestle in a Potter-Elvehjam homogenizer
to promote the release of intracellular contents from lung tissue. The collected homogenate
was filtered through 4-ply gauze to remove large cellular debris. Smaller debris was
pelleted and removed from the homogenate solution via centrifugation at 500 x g for 15
minutes at 2ºC.
Lamellar bodies were isolated and purified from homogenate through the use of
discontinuous sucrose gradients. Briefly, 1.0M sucrose tissue homogenate was layered
below volumes of 0.32M sucrose and 0.68M sucrose before centrifugation in a SW28 rotor
at 64,000 x g for 2 hours at 4ºC with no brake in a Beckman Couture Optima L-80 XP
ultra-centrifuge. The lamellar body containing interfacial band between 0.32M and 0.68M
sucrose was collected. With the aid of a refractometer (ABBE Refractometer, model
A300A, Fisher Scientific Co, Waltham, MA, USA), concentrated 1.0M sucrose was added
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to the collected interfacial materials to produce a sucrose solution of 0.58M. To account
for the lamellar body contribution to refractive index the solution was over-estimated at
0.61M sucrose (Sanders et al., 1980). The lamellar body containing 0.58M sucrose solution
was then layered atop of 0.32M sucrose and 0.45M sucrose before being centrifuged in a
SW28 rotor at 64,000 x g, for 2 hours at 4ºC with no brake in the same ultracentrifuge.
Purified lamellar bodies were collected at the 0.45-0.58M sucrose interfacial band (Gil and
Reiss, 1973; Sanders et al., 1980). Next, the isolated lamellar body solution was diluted to
0.2M sucrose with the aid of the refractometer, and lamellar bodies were pelleted by
centrifuging the collected materials at 40,000 x g for 15 mins at 4ºC. The resulting lamellar
body pellet was resuspended in 300µL of saline and frozen at -4ºC for later analysis.
In the case of lamellar bodies isolated from NV rats for the purposes of TEM
visualization, lamellar bodies were collected in 0.2M sucrose and 0.1M sodium cacodylate
buffer (pH=7.35) with primary fixatives 1.2% glutaraldehyde and 1.2% formaldehyde
(Schmiedl et al., 2005) and were centrifuged at 40,000 x g for 15 minutes at 4ºC to produce
a pellet.

2.5 - Transmission Electron Microscopy
Recovered lamellar body pellets from NV animals were immediately fixed in
sodium cacodylate buffer for 2 hours. Following fixation, samples were washed in buffer,
and stained and fixed with 1% osmium tetroxide for 1 hour. Lamellar body phospholipids
were stained en-bloc overnight with half saturated uranyl acetate and were then dehydrated
using serially increasing acetone to water ratios (Acetone: 20%, 30%, 50%, 70%, 90%,
95%, and 3 x 100%) (Post et al., 1982). Dehydrated samples were embedded in eponaraldite resin and polymerized at 60˚C for 3-5 days. After heating, plastic blocks containing
sample were trimmed and ultra-thin (70nm) sections were cut using an Ultramicrotome
(Reichert-Jung Ultracut E, Leica Microsystems, Wetzlar, DE) and mesh nickel grids.
Lastly, samples were post-stained with 2% uranyl acetate for 15 minutes and 2% lead
citrate for 2 minutes. Isolated samples were washed and dried before imaging with a Philips
CM10 transmission electron microscope at a high voltage between 80-100kV.
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2.6 - Surfactant Biochemical Analyses
2.6.1 – Phosphorus Assay
Aliquots of extracellular surfactant large aggregates and lamellar bodies were
extracted via the method of Bligh and Dyer, and a modified Duck-Chong Phosphorus assay
was used to quantify the phosphorus content (Bligh and Dyer, 1959; Duck-Chong, 1979).
Briefly, samples in saline were extracted by adding chloroform and methanol in a ratio of
1:2:1 (sample: chloroform: methanol) after which the samples were vortexed and
centrifuged at 500 x g for 15 minutes. The chloroform fraction was recovered and 100 µL
of 0.39M Mg (NO3)2 was immediately added to the sample before drying with N2 or O2 gas
over a heated water bath. Dry samples were heated using an electric rack element, and the
resultant residue was resuspended in 1M HCl and heated at 90-100 °C for 15 minutes. The
resulting inorganic phosphate was added to dye consisting of a 3:1 ratio of 0.3% malachite
green and 42% ammonium molybdate (in 3.5M HCl), and 1% Triton-X, to produce an
absorbance product. Five minutes were allowed for completion of the reaction, and
absorbance was read at 655nm and compared to known standards to calculate phosphorus
in each sample. Phospholipid content in each sample was quantified based on phosphorus
measurements.

2.6.2 – Cholesterol Assays
The amount of free cholesterol in extracellular large aggregate samples as a
percentage of total phospholipids was quantified using an enzymatic colorimetric Free
Cholesterol-E assay kit as per the manufacturer’s instructions (Wako Chemicals,
Richmond, VA, USA).
Total cholesterol levels (free and esterified cholesterol) in isolated lamellar bodies
were quantified using an enzymatic colorimetric Amplex Red cholesterol assay kit, as per
manufactures instructions (Thermo Fisher Scientific, Waltham, MA, USA). Briefly,
lamellar body sample, cholesterol esterase, cholesterol oxidase, hydrogen peroxidase, and
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Amplex red reagent were combined and reacted to produce a fluorescent resorufin product.
An incubation period of 1 hour was allowed for the complete liberation of cholesterol esters
(Amundson and Zhou, 1999), after which fluorescence was detected using an absorbance
spectrum of 570 nm and an emission spectrum of 590 nm.

2.7 Surfactant Biophysical Analysis
2.7.1 – Constrained Sessile Drop Surfactometer (CSD)

Surfactant biophysical function was assessed using a constrained sessile drop
surfactometer (CSD) as previously described (Yu et al., 2004). A graphic displaying the
overall set up of the CSD surfactometer is presented in Figure 1.3. Distilled water was
loaded into a 2.5 mL syringe (Hamilton Syringe, Reno, NV, USA) and connected to a
stepping motor (LTA-HS actuator, Newport Corporation, Irvine, CA, USA) connected to
a personal computer. The syringe was connected with tubing to a small, hollowed metal
platform within an environmentally controlled chamber set at 37ºC. In the middle of the
platform, a 3mm diameter pedestal with a razor sharp edge and a 1mm pinhole was
inserted, in direct contact with the tubing attached to the water within the syringe. Water
was then flushed through the tubing from the loaded syringe up out the top of the pedestal
pinhole via control of the stepping motor. The use of custom designed software ‘The
Dropper’ (developed by Yi Zuo, The University of Hawaii at Manoa, 2014) allowed for
experimental control of the stepping motor to promote movement of the syringe piston
forward or backwards within the syringe. Aligned within the horizontal plane of this
pedestal was a red LED spotlight (Telecentric Backlight Illuminator, Edmund Optics,
Barrington, NJ, USA) positioned to illuminate samples atop the pedestal. Planar with the
light source and pedestal was a camera (CMOS monochrome camera, Edmund Optics)
which functioned to record images of samples. Images of samples were rapidly captured at
a rate of 10 frames per second (FPS) and were later analyzed to obtain an accurate
measurement of surface tension and surface area using a software program, ADSA
(Kalantarian et al., 2013).
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2.7.2 – Dynamic Compression-Expansion Cycles
Biophysical activity was assessed by exposing samples to repeated compressionexpansion cycles on the CSD. Aliquots of isolated large aggregate and lamellar body
samples were centrifuged at 21,000 x g for 15 minutes at 2°C to concentrate samples at
2mg/mL phospholipid in buffer (140mM NaCl, 2.5mM HEPES, and 1.5mM CaCl 2,
pH=7.4). Samples were heated at 37º C for at least one hour prior to functional assessment
on the CSD. Small glass beads were added to samples to promote mixing of the sample
prior to analysis. A drop (9-10uL) of a vortexed sample was deposited on the pedestal
within the 37ºC chamber at atmospheric humidity. This drop was allowed to adsorb for
120-180 seconds on the pedestal without manipulation. Following adsorption, 20 dynamic
compression-expansion cycles were completed at a frequency of 30 cycles per minute to
an intended compression of 25-30% original area. One second before the initiation of
dynamic cycling, images were recorded at a rate of 10 FPS, during which captured images
had surface tension to measure adsorption. Images of the sample were acquired at this rate
for the duration of the dynamic cycling. Dynamic compression-expansion cycling occurred
as follows: the sample was first laterally compressed via withdrawal of surfactant subphase (distilled water) into the 1mm pinhole by movement of the motor-driven syringe,
reducing volume and surface area of the sample drop. Following drop compression, the
same volume of hypophase that was removed during compression was inserted back into
the sample through the pedestal pinhole allowing the surfactant sample to expand, and the
cycle was repeated. Following dynamic compression-expansion, recorded images were
analyzed with ADSA to assess surface tension reduction and surface area during the
dynamic cycling. One to four technical replicates of each sample were exposed to dynamic
compression-expansion cycles, depending on sample availability.
An example of a surfactant surface tension versus surface area isotherm and the
associated biophysical parameters relevant to this thesis are shown in Figure 2.3. This
figure illustrates the first compression-expansion cycle of clinical surfactant, BLES, at
2mg/mL phospholipid.

During the first compression cycle, a surfactant sample at

equilibrium is compressed, reducing the surface tension as the area of the sample is
compressed. During expansion, the surfactant sample area increases, along with surface
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tension. The primary outcome of isolated sample biophysical analysis was minimum
surface tension (γ min). Of secondary importance were surface tension after 120-180
seconds of adsorption (γ adsorption), maximum surface tension at each cycle (γ max),
overall compression, and compression required to reach minimum surface tension. In all
compression-expansion isotherms, the lower part of the curve represents the surface
tension achieved during surfactant compression, while the upper portion represents the
surface tension upon expansion.

Figure 2.3 – A representative surface tension (γ) versus surface area (relative area) isotherm
of surfactant (BLES) at the first dynamic compression-expansion cycle assessed on the
constrained sessile drop surfactometer (CSD). Samples are compressed (--o-) and
expanded (-●-). Analysis of isotherms yield information on surface tension following
adsorption (γ adsorption), minimum surface tension (γ min), maximum surface tension (γ
max) as well as maximum compression and compression required to achieve minimum
surface tension.
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2.8 – Statistical Analysis
Technical replicates of surfactant function assessed on CSD are averaged as an
individual data point (except in the presentation of surface tension versus surface area
isotherms). Data is expressed as mean ± standard error (SE). All statistics were performed
using statistical analysis software GraphPad Prism (GraphPad Software, La Jolla, CA,
USA). Probability (p) values of less than 0.05 were considered statistically significant.
Statistical comparisons between surfactant isolated from control and high
cholesterol diet rats within the three experimental models of ARDS measured over the
course of dynamic compression expansion cycling, were assessed by a two-way repeated
measures analysis of variance (ANOVA) with Bonferroni post hoc test. For comparisons
between air instilled and acid instilled rats or between CV-2h and VILI-2h rats with respect
to diet, a two-way ANOVA with a Bonferroni post hoc test was used. An unpaired, twoway student’s T-test was used to determine significance for comparisons between the two
diets within VILI – 3h rats and surfactant depleted rats.
Statistical comparisons between lamellar bodies isolated from VILI and controls
over the course of ventilation or dynamic cycling on the CSD were assessed using a twoway repeated measures analysis of variance (ANOVA) with a Bonferroni post hoc test.
Comparisons between ventilation strategies with regards to biochemical and individual
time point assessments on the CSD were made using a one-way ANOVA with a Tukey
post hoc test.
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Chapter 3 – Results

3.1 – Impact of Diet-Induced Serum Hypercholesterolemia on Surfactant Function
3.1.1 Ventilation Induced Lung Injury – 2 hours
The biophysical analysis of surfactant isolated from rats fed either a normal or high
cholesterol diet and exposed to VILI and CV for 2 hours are shown in Figure 3.1, 3.2, and
Table 3.1. Representative surface tension versus surface area isotherms (at cycle 1 and 10)
during compression-expansion cycles are shown in Figure 3.1. The isotherms of surfactant
obtained from the CV group displayed reduction to low surface tensions upon surfactant
compression, achieving minimum surface tensions of near 5-7mN/m (Fig 3.1A). Isotherms
of surfactant isolated from rats exposed to 2 hours of VILI and fed a high cholesterol diet
(Figure 3.1B), had minimum surface tensions plateau around 12-15mN/m, which was not
observed in normal diet group. In general, the amount of compression required to reach
minimum surface tensions appeared larger in the high cholesterol diet groups at each
ventilation strategy.

Examination of the minimum surface tensions at cycles 1-20 of these samples is
shown in Figure 3.2. There were no differences between diets regarding minimum surface
tension achieved at any cycle measured within the CV or VILI ventilation strategy (Figure
3.2). Furthermore, there was no statistical difference within each diet comparing minimum
surface tension achieved between the two ventilation strategies or between dynamic cycle
numbers (Figure 3.2).
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Figure 3.1 – Representative surface tension (mN/m) versus surface area (fraction of the
initial area) isotherms at dynamic compression-expansion cycles 1 and 10 of surfactant
isolated from rats exposed to two hours of CV (A) and VILI (B) fed a standard or high
cholesterol diet. Compressions are shown in light points (white-standard diet, grey-high
cholesterol diet), while expansions are represented by black points. One technical replicate
is shown.
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Figure 3.2- Minimum surface tension (mN/m) of isolated surfactant during 20 dynamic
compression-expansion cycles from rats fed a standard or high cholesterol diet and
subsequently exposed to two hours of either control ventilation (CV) or VILI. No statistical
significance, P>0.05, n=5-7/treatment groups.

Further quantification and statistical analyses of the data from all isolated surfactant
isotherms is shown in Table 3.1. There was a significant decrease in surface tension
achieved following 120-180 seconds of adsorption on the CSD pedestal in surfactant
isolated from rats fed a high cholesterol diet, compared with rats fed a standard diet
(P<0.05). This was observed in both the CV and VILI ventilation groups. Secondly, all
surfactant isolated from rats fed a high cholesterol diet underwent a significantly larger
maximum compression (expressed as a percentage of initial area) as compared to the
samples isolated from rats fed a standard diet when assessed on the CSD (P<0.05). Thirdly,
during sample re-expansion, there was no difference in absolute maximum surface tension
achieved between diets during dynamic cycling of surfactant obtained from both
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ventilation strategies. However, samples obtained from rats fed a high cholesterol diet
exposed to VILI, tended to achieve maximum surface tensions earlier upon re-expansion,
producing flatter isotherms compared to standard diet fed rats exposed to VILI (Figure
3.1B). Lastly, comparisons between ventilation strategies within each diet generated no
significant differences in any of these measured surfactant biophysical outcomes.

Table 3.1 – Area compression, adsorption, and maximum surface tension of isolated rat
surfactant following 2 hours of mechanical ventilation.
Control Ventilation (CV)
- 2 Hours

Ventilation Induced Lung
Injury (VILI) - 2 Hours

Diet

Standard

High
Cholesterol

Standard

High
Cholesterol

Surface Tension
Following Adsorption
(mN/m)

24.1 ± 0.3

23.2 ± 0.2*

24.5 ± 0.3

22.9 ± 0.1*

Maximum Compression
(Percent original area)

75.68 ± 0.5

73.28 ± 0.4*

75.77 ± 0.3

73.21 ± 0.4*

Area at MST
(Percent of
84.0 ± 1.4
81.6 ± 1.0
76.8 ± 1.6 *
75.7 ± 1.0 *
original area)
Cycle
#1
Maximum
Surface Tension 37.65 ± 2.2 33.98 ± 0.9 39.86 ± 2.2 34.66 ± 1.2
(mN/m)
Area at MST
(Percent of
79.6 ± 0.7
76.0 ± 1.1
75.9 ± 1.5* 78.8 ± 0.5§
original area)
Cycle
#10
Maximum
Surface Tension 40.93 ± 1.8 36.10 ± 0.7 40.87 ± 1.7 36.10 ± 0.8
(mN/m)
*-indicates P<0.05 standard vs. high cholesterol diet, § - indicates P<0.05 cycles 1 vs
cycle 10. n=5-7/treatment group. MST-minimum surface tension.
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3.1.2 Ventilation Induced Lung Injury – 3 hours
A subset of rats was ventilated with a prolonged injurious ventilation protocol,
extending the duration of VILI to three hours. This extended duration was not assessed in
rats exposed to CV. Representative surface tension versus surface area isotherms of
surfactant isolated from rats exposed to VILI for 3 hours at dynamic compressionexpansion cycles 1 and 10 measured in are shown in Figure 3.3, with quantification of
minimum surface tension and other surfactant biophysical parameters shown in Figure 3.4
and Table 3.2, respectively.
All isotherms displayed flattened shapes, exhibiting impaired surface tension
reduction beyond 10 mN/m during instances of compression, particularly at the later
dynamic cycles (Figure 3.3). Generally, isotherms obtained from surfactant isolated from
animals fed either diet displayed the most change in surface tension during the initial
compression (first 5-10% area reduction) as indicated by the steepest slope on the
compression isotherm, while increasing compression beyond these area reductions caused
the slope of the isotherm to become shallower, and low surface tensions were not achieved.
When statistically comparing the minimum surface tension achieved by these surfactant
samples, it was found that there were no significant differences between surfactant isolated
from rats fed either diet (Figure 3.4). Additionally, there was no difference in minimum
surface tension achieved over the course of continuous dynamic cycling (Figure 3.4).
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Figure 3.3 – Representative surface tension (mN/m) versus surface area (fraction of the
initial area) isotherms at dynamic compression-expansion cycles 1 and 10 of surfactant
isolated from rats fed a standard or high cholesterol diet and exposed to VILI for 3 hours.
Compressions are shown in light points (white-standard diet, grey-high cholesterol diet),
while expansions are represented by black points. One technical replicate is shown.
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Figure 3.4 - Minimum surface tension achieved (mN/m) by surfactant during 20 dynamic
compression-expansion cycles, isolated from rats exposed to a standard or high cholesterol
diet and three hours of VILI. No statistical significance, P>0.05, n=6-7/diet.

The surface tension following adsorption, maximum surface tensions, and
compressions (as a fraction of the initial area) measured during the biophysical assessment
of surfactant obtained from rats fed a standard and high cholesterol diet exposed to VILI
for three hours are shown in Table 3.2. Surfactant samples isolated from high cholesterol
diet rats had a significantly lower surface tension measured following 120-180 seconds of
adsorption upon the CSD pedestal compared to surfactants isolated from rats fed a standard
diet (P<0.001). Secondly, much like the 2 hour CV and VILI groups (Table 3.1), samples
obtained from rats fed a high cholesterol diet were exposed to increased compression (as a
percentage of initial area) during analysis on the CSD as compared to rats fed a standard
diet (P<0.001). Additionally, surfactant obtained from rats fed a high cholesterol diet had
their minimum surface tensions achieved at larger compression distances for both cycles
investigated. Lastly, surfactant samples isolated from rats fed a high cholesterol diet had
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significantly reduced maximum surface tensions upon sample expansion as compared to
surfactant isolated from rats fed a standard diet. Furthermore, there were no significant
differences between any parameter comparing dynamic cycle 1 and 10.

Table 3.2 – Area compression, adsorption, and maximum surface tension of surfactant
isolated from rats exposed to three hours of VILI
Ventilation Induced Lung
Injury (VILI) - 3 Hours
Diet

Standard

High
Cholesterol

Surface Tension Following
Adsorption
(mN/m)

25.3 ± 0.6

23.0 ± 0.2 *

Maximum Compression
(Percent of original area)

76.6 ± 0.4

73.3 ± 0.5*

Area at MST
(Percent of original
area)

83.9 ± 1.2

76.1 ± 0.7*

Maximum Surface
Tension
(mN/m)

42.36 ± 1.7

34.98 ± 1.2*

Area at MST
(Percent of original
area)

81.4 ± 1.1

75.6 ± 1.1*

Maximum Surface
Tension
(mN/m)

44.6 ± 2.2

34.56 ± 1.3*

Cycle
#1

Cycle
#10

*-indicates P<0.05 - standard versus high cholesterol diet. n=6-7/diet group. MSTminimum surface tension
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3.1.3 Acid Aspiration
The second injury model examined in our diet study was acid aspiration.
Representative surface tension versus surface area isotherms during dynamic compressionexpansion cycles 1 and 10 of surfactant isolated from rats exposed to air and acid aspiration
are shown in Figure 3.5, with quantification of minimum surface tension and other
surfactant biophysical parameters from all samples assessed in these groups shown in
Figure 3.6 and Table 3.3, respectively.
Isotherms of extracellular surfactant isolated from rats exposed to the air control
group were similar between the two diets at each respective cycle number (Figure 3.5A).
Additionally, isotherms of surfactant isolated from acid exposed rats demonstrated similar
isotherms between the two diets (Figure 3.5B).
Minimum surface tensions were not different between rats fed a standard or high
cholesterol diet exposed to air aspiration (Figure 3.6). There were several differences
however, as acid administered rats exposed to a high cholesterol diet exhibited higher
minimum surface tensions during compression at cycle’s #9-13, and 16, as compared to
standard diet counterpart rats (Figure 3.6). There was no difference in surfactant minimum
surface tension achieved within each diet, regardless of material instilled (Figure 3.6).
Furthermore, there was no difference in minimum surface tension achieved over the course
of dynamic cycling as compared to cycle #1 in any of the four surfactant samples (Figure
3.6).

59

Figure 3.5 - Representative surface tension (mN/m) versus surface area (fraction of the
initial area) isotherms at dynamic compression-expansion cycles 1 and 10 of surfactant
isolated from rats fed a standard or high cholesterol diet, exposed to air aspiration (A) and
acid aspiration (B) followed by 120 minutes of non-injurious mechanical ventilation.
Compression is shown in light points (white-standard diet, grey-high cholesterol diet),
while expansion is represented by black points. One technical replicate is shown.
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Figure 3.6- Minimum surface tension (mN/m) of surfactant during 20 dynamic
compression-expansion cycles, isolated from rats fed a standard or high cholesterol diet
and exposed to air and acid aspiration followed by 2 hours of baseline mechanical
ventilation. *- indicates P<0.05, high cholesterol diet versus standard diet exposed to acid,
n=4-9/treatment group.

The additional outcomes of surfactant biophysical assessment, obtained from rats
fed a standard and high cholesterol diet exposed to air or acid aspiration, are shown in
Table 3.3. Surfactant isolated from rats fed either diet and exposed to either air or acid
aspiration, did not have any significant difference between them regarding surface tension
achieved following 120-180 seconds of adsorption on the CSD pedestal. During sample
compression on the CSD, all four sample groups achieved very comparable maximum
compressions (~76% original area), although there was a significantly reduced
compression as percentage of initial area required to achieve minimum surface tension at
the first dynamic cycle for surfactant isolated from air instilled hypercholesterolemic rats
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compared to normocholesterolemic counterparts (P<0.05). Overall, there were no
differences in surfactant sample compression between acid exposed animals. There was no
difference in maximum surface tension achieved between diets regarding surfactant
collected from the air instilled animals. However, in animals exposed to acid aspiration,
maximum surface tension of surfactant isolated from rats fed a high cholesterol diet was
significantly reduced compared to those fed a standard diet at both cycles investigated.
Lastly, it should be noted that there were no significant differences between any surfactant
biophysical parameters comparing the material instilled within each diet.

Table 3.3 – Area compression ratios, adsorption, and maximum surface tension of
surfactant isolated from rats exposed air or acid aspiration.
Air Aspiration

Acid Aspiration

Diet

Standard

High
Cholesterol

Standard

High
Cholesterol

Surface Tension
Following Adsorption
(mN/m)

23.5 ± 0.2

23.0 ± 0.3

23.1 ± 0.2

22.7 ± 0.1

Maximum Compression
(Percent of original area)

75.9 ± 0.4

76.2 ± 0.4

76.1 ± 0.4

76.0 ± 0.5

Area at MST
(Percent of
78.2 ± 0.5
79.0 ± 0.4 79.1 ± 0.6
80.2 ± 0.5*
original area)
Cycle
Maximum
#1
Surface
36.3 ± 0.6
35.1 ± 1.0
35.2 ±0.7 32.9 ± 0.4*
Tension
(mN/m)
Area at MST
(Percent of
77.8 ± 0.3
78.8 ± 0.3
79.0 ± 0.4 79.1 ± 0.6
original area)
Cycle
Maximum
#10
Surface
36.5 ± 0.5
34.9 ± 1.2
35.9 ± 0.6 33.0 ± 0.5*
Tension
(mN/m)
*-indicates P<0.05 – standard diet versus high cholesterol diet. n=4-9/treatment group.
MST-minimum surface tension
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3.1.4 – Surfactant Depletion
The third model for which the biophysical function of isolated extracellular
surfactant was measured was that of surfactant depletion. Similar to the previous two injury
models, representative surface tension versus surface area isotherms during dynamic cycles
1 and 10 of extracellular surfactant obtained from rats exposed to surfactant depletion and
2 hours of mechanical ventilation are displayed in Figure 3.7, and quantified data is
presented in Figure 3.8 and Table 3.4.
Comparing isotherms between diets at each cycle, surfactant isolated from rats fed
a standard diet exhibited the tendency to reach very low surface tensions (~5mN/m), while
surfactant from rats fed a high cholesterol diet had impaired minimum surface tension, only
reaching surface tension of 10-15mN/m at maximal of area compression (Figure 3.7).
When this was quantitatively compared, surfactant isolated from rats fed a high cholesterol
diet had significantly higher minimum surface tensions achieved at cycles # 4, 8-15, and
17-20, compared to surfactants isolated from rats fed a standard diet (Figure 3.8). There
was no statistical difference in surface tension reduction over the course of dynamic cycling
as compared to cycle 1 in surfactants obtained from both diets (Figure 3.8).
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Figure 3.7 – Representative surface tension (mN/m) versus surface area (fraction of the
initial area) isotherms at dynamic compression-expansion cycles 1 and 10 of surfactant
isolated from rats fed a standard or high cholesterol diet, exposed to surfactant depletion
followed by 120 minutes of mechanical ventilation. Compression is shown in light points
(white-standard diet, grey-high cholesterol diet), while expansion is represented by black
points. One technical replicate is shown.
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Figure 3.8 - Minimum surface tension (mN/m) of isolated surfactant during 20 dynamic
compression-expansion cycles from rats exposed to a standard or high cholesterol diet
followed by surfactant depletion and mechanical ventilation for 2 hours. *- indicates
P<0.05 – standard versus high cholesterol diet, n=8/treatment group.

Within surfactant depleted sample biophysical analysis, it was also found that there
was no difference between diets in regards to surfactant surface tension achieved following
120-180 seconds of adsorption on the CSD platform (Table 3.4). Assessment of
compression percentage of the original sample area revealed that during dynamic cycling
of surfactant from both diets, samples were maximally compressed to the same extent
(~74.5% of initial area), and there was no difference in compression required to achieve
minimum surface tension. However, at cycle 10, surfactant isolated from rats fed a high
cholesterol diet was able to reach minimum surface tensions after less compression
compared to those of the standard diet. Maximum surface tensions achieved upon sample
re-expansion were not significantly different between diets at any cycle measured.
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Table 3.4– Area compression, adsorption, and maximum surface tension of surfactant
isolated from rats exposed to surfactant depletion.

Surfactant Depletion
Diet

Standard

High
Cholesterol

Surface Tension Following
Adsorption
(mN/m)

24.15 ± 0.3

24.09 ± 0.2

Maximum Compression
(Percent of original area)

74.3 ± 0.2

74.7 ± 0.3

Area at MST
(Percent of original
area)

76.8 ± 0.5

78.2 ± 0.7

Maximum Surface
Tension
(mN/m)

37.56 ± 1.1

35.72 ± 0.8

Area at MST
(Percent of original
area)

76.8 ± 0.2

80.5 ± 1.0*

Cycle
#1

Cycle
#10

Maximum Surface
37.95 ± 1.1
36.51 ± 0.8
Tension
(mN/m)
*- indicates P<0.05 standard vs high cholesterol diet, n=8/treatment group MST
minimum surface tension
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3.2 - Impact of VILI on Lamellar Body Surfactant
The second set of experiments focused specifically on the lamellar body fraction
of surfactant in a three-hour model of VILI.

3.2.1 - Physiology during Ventilation
The arterial oxygenation measured throughout the course of three hours of CV and
VILI are shown in Figure 3.9. All rats maintained arterial oxygenation at baseline values
up until 150 minutes into mechanical ventilation. At this time point, significant reductions
in arterial oxygenation were observed in rats exposed to VILI compared to CV.
Furthermore, at 150 minutes of ventilation and through to the end of 180 minutes of
ventilation, rats exposed to VILI had significantly lower arterial blood PaO2: FiO2 as
compared to CV rats. Rats exposed to CV did not achieve differences in arterial
oxygenation as compared to baseline at any point during ventilation.
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Figure 3.9 – Arterial oxygenation (mmHg) measured in rats throughout the course of three
hours of control ventilation (CV) or VILI. # - P<0.05 CV vs. VILI, § - P<0.05 baseline vs.
time point of VILI rats. n=6/treatment group.
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Additional measurements of physiological parameters recorded in rats at baseline
and end of mechanical ventilation are shown in Table 3.5. Firstly, none of the physiological
parameters measured between CV and VILI rats at baseline were significantly different.
Secondly, after three hours of CV or VILI mechanical ventilation, significant increases in
peak inspiratory pressure (PIP) and reductions in blood pressure were measured at the end
of ventilation as compared to baseline measurements. Comparing the two ventilation
strategies, VILI promoted significant increases in PIP as compared to those measured in
rats exposed to CV, however no other differences in measured physiology were observed
between the ventilation strategies. Lastly, three hours of CV promoted significant increases
in heart rate as compared to baseline; a phenomenon not observed in rats exposed to VILI.

Table 3.5 – Physiological measurements of ventilated rats.
Physiological
Parameter

Control Ventilation (CV)

VILI

Baseline

180 minutes

Baseline

180 Minutes

PIP (cmH2O)

10.4 ± 0.4

14.6 ± 0.2§

10.25 ± 0.4

30.9 ± 1.6§, #

PaCO2 (mmHg)

33.0 ± 1.4

35.8 ± 1.6

32.8 ± 1.2

36.7 ± 2.4

Blood Pressure
(cmH2O)

173.0 ± 8.6

79.2 ± 5.1§

161.3 ± 9.2

50.4 ± 6.3§

Heart Rate (bpm)

243.8 ± 5.0

266.8 ± 23.2§

236.5 ± 15.9

238.5 ± 9.5

# - P<0.05 – control ventilation vs. VILI. § - P<0.05 – baseline vs. 180 mins,
n=6/treatment group. Bpm – beats per minute,

3.2.2 – Verification of Lamellar Body Isolation
Lamellar bodies were isolated from NV rats to confirm the isolation technique.
Representative TEM images of lamellar body samples are shown in Figure 3.10. Images
showed isolation of lamellar body structures without the presence of other identifiable
cellular structures, such as mitochondria. Lamellar bodies displayed characteristic features
of dense osmiophilic folds of phospholipids surrounded by an intact limiting membrane.
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Figure 3.10 – Representative TEM images of isolated lamellar bodies from NV rat lungs.
Images show collected pellets of intact lamellar bodies at magnifications of 4,600x (A) and
92,000x (B). Scale bar in B represents 100nm.

3.2.3 – Biochemical Analysis and Quantification
Phospholipid and relative cholesterol (% of phospholipid) measured in isolated
lamellar bodies are shown in Figure 3.11. CV rats ventilated for 180 minutes resulted in
significant increases in total phospholipid levels recovered in the lamellar bodies (3.11A)
following the isolation process as compared to both NV rats and VILI rats. However, there
was no difference in recovered lamellar body phospholipid between NV animals and those
exposed to VILI. Quantification of total cholesterol (free cholesterol + esterified
cholesterol) as a percentage of phospholipid obtained in isolated lamellar bodies (3.11B)
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yielded no statistically significant differences in the relative amount of cholesterol
composing lamellar body surfactant material following exposure to different ventilation
strategies.
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Figure 3.11 – Phospholipid (mg/Kg BW) (A) and total cholesterol as a percentage of
phospholipids (B) recovered in isolated lamellar bodies from non-ventilated rats, or rats
exposed to three hours of CV and VILI. # - indicates P<0.05 CV and NV vs. VILI, n=68/treatment group.
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3.2.4 – Biophysical Analysis
Following isolation and analysis of lamellar body phospholipid and cholesterol
content, isolated lamellar body samples had their biophysical properties assessed on the
CSD. Representative surface tension versus surface area isotherms of isolated lamellar
bodies are shown in Figure 3.12. Whereas these representative isotherms illustrate the
overall surfactant surface tension changes during cyclical compression and expansion of
the representative samples, the quantification and statistical analysis of minimum surface
tension and other biophysical parameters from all lamellar body samples are shown in
Figure 3.13 and Table 3.6, respectively.
Lamellar bodies isolated from NV and CV rats displayed low surface tensions upon
the first compression (<5mN/m), while rats exposed to VILI had an impaired ability to
reduce surface tension at cycle #1, reaching surface tension of 15mN/m (Figure 3.12).
Repeated dynamic cycling lowered the minimum surface tension achieved in all lamellar
body samples compared to the first dynamic cycle. Statistically comparing the surface
tension reduction of lamellar body samples obtained from rats exposed to various
ventilation patterns, it was demonstrated that rats exposed to VILI had significantly higher
minimum surface tensions achieved compared to associated controls. The impairment
associated with VILI lamellar body samples was statistically different at cycles 1-10, and
cycles 1-14 and 18 compared to the minimum surface tension of surfactant obtained from
CV and NV rats, respectively (Figure 3.13). There were no significant differences in
surface tension reduction upon compression of isolated lamellar bodies between NV and
CV samples. Comparing minimum surface tensions achieved over the course of dynamic
cycling, it was demonstrated that significant reductions in minimum surface tension were
achieved as compared to cycle 1 for both NV (cycle 2 and onward) and VILI (cycle 3 and
onwards) exposed animals.
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Figure 3.12 - Representative surface tension (mN/m) versus surface area (fraction of the
initial area) isotherms at dynamic compression-expansion cycles 1 and 10 of lamellar
bodies isolated from NV rats or rats exposed to three hours of CV or VILI. Compression
is shown in white points, while expansion is represented by black points. One technical
replicate is shown.
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Figure 3.13 - Minimum surface tension (mN/m) of isolated lamellar bodies during 20
dynamic compression-expansion cycles from NV rats, or rats exposed to 3 hours of
control ventilation (CV) or VILI. * indicates P<0.05 –NV vs VILI, # indicates P < 0.05 CV vs VILI, n=6-8/treatment group.

The additional outcomes of isolated lamellar body biophysical assessment are
shown in Table 3.6. Firstly, there were no significant differences between VILI and
controls with respect to the surface tension achieved following 120-180 seconds lamellar
body sample adsorption on the CSD pedestal. Secondly, all lamellar body samples
regardless of origins were compressed the same extent during the biophysical assessment,
as indicated by maximum compression at cycle 1. Although there were no differences in
area compression required to achieve minimum surface tension between the different
ventilation strategies, lamellar bodies isolated from NV rats required significantly less
compression to achieve minimum surface tension at cycle 10 as compared to cycle 1.
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Thirdly, there were no differences in maximum surface tension between lamellar bodies
isolated from rats exposed to VILI or associated controls achieved during dynamic cycles
1 or 10.

Table 3.6– Area compression, adsorption, and maximum surface tension of lamellar
bodies isolated from rats exposed to ventilation

NV

CV

VILI

Surface Tension Following
Adsorption
(mN/m)

23.2 ± 0.3

22.9 ± 0.2

24.1 ± 0.4

Maximum Compression
(Percent of original area)

73.6 ± 0.6

71.7 ± 0.8

73.0 ± 0.7

Area at MST
(Percent of original
77.5 ± 0.8
76.5 ± 0.9
76.6 ± 0.8
area)
Cycle
#1
Maximum Surface
34.0 ± 0.8
32.4 ± 0.6
32.3 ± 0.6
Tension
(mN/m)
Area at MST
(Percent of original
78.7 ± 1.4
78.6 ± 1.4
81.0 ± 0.6§
area)
Cycle
#10
Maximum Surface
34.3 ± 0.4
33.6 ± 0.6
33.8 ± 1.0
Tension
(mN/m)
§ indicates P<0.05 – cycle 1 versus cycle 10, n=6-8/treatment group. MST-minimum
surface tension
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Chapter 4: Discussion and Conclusions

4.1 Overview
During ARDS and associated mechanical ventilation, pathophysiological changes
occur in the lung, including alterations to the endogenous pulmonary surfactant system.
These surfactant alterations contribute to impairments in biophysical function, most
importantly impaired surface tension reduction, contributing toward the progression of
lung injury within ARDS patients. The objective of this thesis was to investigate the
alterations and impairments of surfactant biophysical function that occur in the context of
lung injury, with a specific focus on VILI.
The biophysical analysis of extracellular surfactant isolated from rats fed a standard
and high cholesterol diet presented in this thesis were obtained from a previously
performed study within our lab (Qua Hainsen, 2013). This study focused on changes in
lung physiology and surfactant composition induced by a high cholesterol diet following
exposure to three distinct models of lung injury. The results from the initial study and the
biophysical analysis of the samples presented in this thesis were combined and recently
published (Milos et al., 2016). Therefore, the initial part of this discussion will focus on
the combined observations of these studies, leading to the first conclusion that serum
hypercholesterolemia does not lead to increased severity of lung injury. Secondly, this
discussion will focus in-depth on the analysis of surfactant biophysical function assessed
using the CSD. The biophysical assessment of surfactant allows for a comprehensive
evaluation of surfactant function in the context of exposure to a high cholesterol diet and
lung injury. This leads to the second conclusion that despite the absence of changes in the
severity of lung injury, a high cholesterol diet promotes significant alterations to surfactant
biophysical function during injury. Finally, a study involving the investigation of lamellar
bodies isolated from rat lungs exposed to VILI provides a unique characterization of
intracellular surfactant biophysical function following injury. This analysis provides the
basis for the third conclusion that VILI induces intracellular changes which impair the
biophysical activity of the lamellar body derived surfactant.
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4.2 – Diet-Induced Serum Hypercholesterolemia– Combined Studies
It has been demonstrated that elevated levels of cholesterol within surfactant impair
its function (Gunasekara et al., 2005) and that this type of biophysical inhibition occurs in
VILI (Panda et al., 2004; Vockeroth et al., 2010). However, it was unknown whether high
serum cholesterol impacts surfactant cholesterol alterations during lung injury. Therefore,
the effect of diet-induced serum hypercholesterolemia on the severity of lung injury was
investigated in three independent, clinically relevant rat models of ARDS. Based on the
observation that the majority of surfactant cholesterol is derived from the serum, it was
hypothesized that a high cholesterol diet would lead to increased severity of lung injury
outcomes due to increased incorporation of cholesterol into surfactant membranes,
impairing surfactant biophysical function.
The overall findings of these studies demonstrated that despite achieving
significantly increased serum cholesterol levels, a high cholesterol diet did not increase the
susceptibility to lung injury, as indicated by typical markers of pulmonary function, such
as PaO2:FiO2 and PIP (see Table 1.1), across all three models lung injury. Furthermore,
serum hypercholesterolemia induced by the diet did not affect surfactant pool sizes or
cholesterol content recovered in surfactant large aggregates within any model of injury or
their associated controls (see Table 1.2). Interestingly considering the lack of differences
in physiology and surfactant composition, a high cholesterol diet promoted significant
impairments in surface tension reduction within acid aspiration and surfactant depletion
models of lung injury compared to rats fed a standard diet. Therefore, in these two models,
it appeared a high cholesterol diet had an effect on surfactant surface tension reducing
capabilities as assessed on the CSD. However, these impairments in surface tension
reduction measured in vitro were not of sufficient magnitude to affect lung function.
Therefore, it is concluded that serum hypercholesterolemia is not a significant risk factor
for increased severity or susceptibility towards lung injury.
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The reported observation of elevated cholesterol content recovered in lavage
surfactant of experimental animal models has been largely restricted to studies
investigating VILI (Panda et al., 2004; Maruscak et al., 2008; Vockeroth et al., 2010). Thus,
it was unknown whether significant increases in surfactant cholesterol occurred in the
context of other initiating insults of lung injury. In order to thoroughly investigate the
contribution of a high cholesterol diet on surfactant cholesterol content and its subsequent
impact on its biophysical function, three distinct animal models of ARDS were utilized.
The use of high VT and 0 cmH2O PEEP was employed to study the effects of alveolar
over-distension and repeated collapse (VILI) on surfactant cholesterol content since
increases in surfactant associated cholesterol had previously been described in the lavage
of animals exposed to this type of injury. Acid aspiration, modelled gastric acid inhalation,
allowed for a clinically relevant assessment as to whether high serum cholesterol
predisposes a risk toward impairments in surfactant biophysical function. This type of
injury occurs due to a chemical burn in the lung and promotes significant inflammation
and leakage of contents from the serum into the alveolar airspaces (Aspros et al., 2010;
Reiss et al., 2012). Lastly, a model of surfactant depletion combined with mechanical
ventilation was utilized to induce lung dysfunction and to allow de novo surfactant
secretion (Bailey et al., 2004). Despite the various lung pathologies associated with each
model injury, the lack of differences regarding lung physiology and surfactant cholesterol
content induced by the diet across all models provides strong evidence to for us to suggest
that serum hypercholesterolemia does not influence the development or severity of lung
injury.
Upon comparison of cholesterol content recovered in surfactant obtained from
lavage of all rat models of ARDS (Table 1.2), it was observed that only rats exposed to
three hours of VILI had significantly elevated levels of cholesterol in surfactant compared
to naive rats (Milos et al., 2016). Considering other reports also demonstrating this
observation, we speculate that high surfactant cholesterol may be a specific biomarker
indicative of exposure to VILI. Although investigation into other models of lung injury is
required to determine if high surfactant cholesterol is truly specific to the damaging effects
of mechanical ventilation, evidence limiting surfactant cholesterol increases to VILI
suggest that the changes are likely mediated by altered mechanotransduction signalling
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within the alveolar epithelial cells upon exposure to forces such as over-distension or shear
stress during alveolar collapse (Vlahakis and Hubmayr, 2003). Furthermore, a recent
preliminary clinical study has suggested that cholesterol mediated surfactant impairment
may be relevant in human patients receiving mechanical ventilation (Qua Hiansen et al.,
2015). When surfactant isolated from the lavage of severely injured trauma patients
undergoing mechanical ventilation had surfactant cholesterol removed using chemical
sequestration with MβCD, surfactant’s biophysical function was greatly improved (Qua
Hiansen et al., 2015). Although it has not been proven that these cholesterol increases are
due to alveolar over-distention and repeated collapse, this study provides evidence to
suggest that increased cholesterol in surfactant may play a role in the surfactant dysfunction
of these ventilated patients. Thus it is speculated that increases in surfactant cholesterol are
sequela of lung injury incurred exclusively during the process of injurious mechanical
ventilation.
Finally, it is concluded that elevated cholesterol recovered in lavage surfactant was
unlikely to be caused by excessive leakage from the serum. In injury models of acid
aspiration and VILI, there was diffuse endothelial-epithelial barrier damage as indicated
by high protein content recovered in the lavage of rats fed both a standard and a high
cholesterol diet with no significant difference in protein recovered between diets (data not
shown). Thus, if cholesterol levels were increasing in lavage due leak from the serum, it
would be expected that there would be higher levels of cholesterol recovered in the lavage
of both the acid and VILI exposed rats fed a high cholesterol diet compared to the standard
diet, which was not observed. Thus, our results indicate to us that elevated cholesterol in
surfactant is a consequence of the damaging effects of mechanical ventilation, regardless
of diet.
When interpreting the results of this study investigating the alterations to surfactant
and lung physiology upon exposure to acute serum hypercholesterolemia, it is important to
consider limitations. The acute duration of a high cholesterol diet (17-20 days) used in this
study is not reflective of the human condition. Typically in humans, serum
hypercholesterolemia is induced through intake of high fat and high cholesterol foods over
the span of several years (Civin, 1972). In this study, our short duration high cholesterol
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diet was used to avoid induction of confounding cardiovascular and disease co-morbidities.
Additionally, the injury models used were of relatively short duration, limited three hours
of mechanical ventilation. In reality, ARDS patients require ventilation for several days to
weeks before lung injury may be resolved, pending severity of disease (Ranieri et al.,
2012). It is possible that a longer duration of exposure to serum hypercholesterolemia or
increased duration of mechanical ventilation (with clinically relevant protective ventilation
strategies) may have impacted cholesterol incorporation into surfactant differently,
however this remains to be investigated.
In summary, our results demonstrate a high cholesterol diet does not impact the
progression or severity of lung injury through alterations in surfactant cholesterol content.
However, observations from functional biophysical analysis led us to speculate that high
serum cholesterol levels may predispose to cholesterol-independent impairments in
surfactant biophysical function following exposure to lung injury. Furthermore, increases
in surfactant-associated cholesterol were only observed in the VILI model of lung injury
following short injury times periods, suggesting increases in surfactant cholesterol may be
related to the damaging effects of alveolar over distension and repeated collapse and reopening.

4.3 – Diet-Induced Serum Hypercholesterolemia – Biophysical Studies
Although there were no differences with respect to physiology or surfactant content
measured between the two diets, the second component of this investigation was to provide
an in-depth biophysical evaluation of surfactants isolated from rats fed these diets.
Assessing surfactant biophysical alterations after exposure to a high cholesterol diet would
allow us to further assess our hypothesis that serum hypercholesterolemia is a risk factor
for increased susceptibility toward the development of more severe lung injury.
The major findings of surfactant biophysical assessment on the CSD were that there
are alterations to all three biophysical parameters measured between the two diets in our
various injury models. It is important to note that during biophysical assessment, surfactant
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samples were generally compressed to the same relative area between the two diets
allowing for accurate comparisons between the other biophysical parameters. The
exceptions to this were due to technical issues, and in these cases, samples between the two
diets were compressed slightly differently. Nevertheless, within each model of lung injury,
minimum surface tension achieved during surfactant film compression was impaired when
isolated from hosts fed a high cholesterol diet compared to standard diet counterparts. A
second general trend regarding surfactant biophysical function from hypercholesterolemic
rats compared to standard diet rats, was lower maximum surface tension achieved upon
dynamic expansion. Lastly, although only observed in the surfactant isolated from rats
exposed to the VILI model of injury, surfactant isolated from rats fed a high cholesterol
diet had improved ability to adsorb to the air-liquid interface. These results collectively
implicate a high cholesterol diet in modulating surfactant function. It should be appreciated
that these alterations in function were observed independently of increased cholesterol
incorporation into surfactant membranes across all models of experimental lung injury and
diet, inferring a role of unknown contributors toward these surfactant alterations.
The overall finding that serum hypercholesterolemia did not promote increases in
surfactant cholesterol is in contrast to a previously published report (McCrae et al., 2008).
This study performed by McCrae and colleagues demonstrated one month of feeding
adolescent female mice a high cholesterol diet successfully induced increases in surfactant
associated cholesterol in the alveolar lavage (12 mol%) compared to a standard diet fed
mice (7 mol%). Alternatively, several other studies have investigated the effect of
pharmacologically lowering serum cholesterol on surfactant function. When rat serum
cholesterol levels were successfully lowered with treatment of an intraperitoneal injection
of 1 4-aminopyrazolo [3,4-d] pyrimidine, there was no difference in cholesterol quantities
recovered in lamellar body or extracellular surfactant fractions compared to untreated rats
with normal serum cholesterol levels (Suzuki and Tabata, 1980; Davidson et al., 1997).
Although these two latter studies suggest a role of the AIIE in equilibrating surfactant
cholesterol when availability is low, it is possible that differences in experimental design
such as method used to alter serum cholesterol, organismal species, and host species age
and sex, may have contributed to the observed differences in surfactant cholesterol content
induced by altered serum cholesterol levels.
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Although a discrepancy exists between various experimental studies in regards to
changes to surfactant cholesterol induced by altering dietary cholesterol, our study and
studies by McCrae and Davidson collectively suggest altered serum cholesterol content
detrimentally impacts surfactant function in rodent animal models. When surfactant
function was assessed with a capillary surfactometer designed to assess unrestricted air
flow through a capillary tube, surfactants isolated from the lavage of high cholesterol diet
mice had impaired patency or an inability to maintain airway flow, compared to surfactant
isolated from those fed a standard diet (McCrae et al., 2008). Conversely, surfactant
biophysical function from serum hypo-cholesterolemic rats was assessed at 3mg/mL
phospholipid using a pulsating bubble surfactometer, and demonstrated impaired reduction
to low minimum surface tensions during compression compared to rats with normal serum
cholesterol (Davidson et al. 1997). Taken together, the results from these studies suggest
an important role of normal serum cholesterol levels in vivo towards the biophysical
function of surfactant in vitro, acting independently of actual cholesterol incorporation into
surfactant films. Because there are only a limited number of studies investigating surfactant
function associated with altered serum cholesterol, additional studies are required to
confirm this relationship and determine such a mechanism by which physiologically
normal serum cholesterol levels may help maintain proper surfactant biophysical function.
Although a diet high in cholesterol appeared to impact surfactant’s biophysical
behaviour, there were no differences measured in regards to known mediators of surfactant
dysfunction between the two diets. Therefore, we speculate that intake of a high cholesterol
diet may have caused alterations in surfactant phospholipid composition. Indeed, previous
studies investigating the impact of higher levels of various dietary lipids on pulmonary
surfactant have produced findings demonstrating alterations to phospholipid species
recovered in surfactant lavage (Kyriakides et al., 1976; Burnell et al., 1978; Alam and Alam
1984; Wolfe et al., 2002; Murray et al., 2000). For example, rats fed a diet free of essential
fatty acids or a diet high in saturated fat, had significantly reduced recovery of DPPC
recovered in lavage (Kryiakides et al., 1976; Burnell et al., 1978; Alam and Alam 1984).
Furthermore, surfactant from the lungs of these animals fed a diet free of essential fatty
acids were associated with significant impairments in minimum surface tension reduction,
likely related to reduced DPPC content (Burnell et al., 1978). Other studies investigating
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the role of a diet high in fatty acids such as linoleate or unsaturated fish oils, have
demonstrated AIIE cells may favour the incorporation of fatty acids that are abundant in
the blood serum into surfactant phospholipid films (Murray et al., 2000; Wolfe et al., 2002).
The tendency to favour incorporation of unsaturated fatty acids into surfactant
phospholipids may result in reduced saturated surfactant composition, altering fluidity and
diminishing the capacity for surfactant to reduce surface tension to very low values upon
compression. In our study, it is speculated that serum hypercholesterolemia may have had
an alternate effect beyond simply raising cholesterol in serum, impacting the serum fatty
acid profile and altering the relative composition of surfactant phospholipids.
The collective alterations to surfactant biophysical function measured in rats
exposed to serum hypercholesterolemia and lung injury provide evidence for us to suggest
the diet has induced alterations to surfactant film fluidity. Evidence from previous in vitro
studies have demonstrated that increasing amounts of fluidizing components in surfactant
phospholipid mixtures (such as unsaturated phospholipids), promotes impaired surface
tension reduction upon compression and enhanced adsorption and re-spreading upon film
formation (Taneva and Keough, 1997; Lee, 2008; Hawco et al., 1981; Notter et al., 1980).
Based on our findings that a high cholesterol diet induced similar biophysical changes
across all surfactant samples obtained from three models of lung injury, we suspect this
diet may have increased the amounts of unsaturated phospholipids and reduced the amount
of DPPC present in surfactant. To help confirm such alterations to fluidity induced by the
diet, the phospholipid species present in surfactant obtained from both diets needs to be
assessed.
Considering the importance of surface tension reduction for alveolar stability
during exhalation, it was notable that impaired surface tension was not correlated with
increased severity of lung injury in hypercholesterolemic animals. We provide several
possible explanations for these findings. First, the discrepancy may have arisen due to the
environment in which surfactant function was assessed in vitro, and the environment in
vivo at which surfactant acts to stabilize the lung. In our study, assessment of surfactant
biophysical function occurred at relatively low concentrations of 2mg/ml phospholipid.
This concentration is much lower than what has been estimated to be found lining the lung
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of small mammals, ~30mg/mL in adult rats, and ~120 mg/mL in rabbits (Ohashi et al.,
1994; Putz et al., 1994). Moreover, low concentrations of surfactant phospholipid are more
susceptible to biophysical impairments by serum proteins or high levels of cholesterol
(Zasadzinski et al., 2005; Gunasekara et al., 2005); increasing the phospholipid
concentrations improves its interfacial biophysical properties. Second, the impaired
minimum surface tension upon compression noticed in the high cholesterol diet groups
compared to the control diet group was counterbalanced by the differences in re-spreading
capabilities as indicated by lower maximum surface tension during sample re-expansion
between the two diets. Therefore, it is possible that despite high cholesterol diet surfactant
samples not being able to stabilize the lung at low volumes as well as the standard diet
group, the surfactant from this group was able to adsorb and re-form a surface active
membrane upon expansion more efficiently helping to reduce surface tension during
inspiration, and reducing the work of breathing. Finally, it is possible that although the
sensitivity of the CSD allowed us to observe statistically significant differences between
samples, the magnitude of changes between the two different diets was relatively small and
likely not sufficient to be reflected in physiological differences. For example, the
differences in minimum surface tension detected in our study were ~5mN/m, whereas in
previous studies by Veldhuizen et al., and Vockeroth and colleagues have demonstrated
differences on the order of 15-20mN/m to be associated with altered lung physiology
(Veldhuizen et al., 1997; Vockeroth et al., 2010).
In summary, our results demonstrate that upon initiation of lung injury and
exposure to a high cholesterol diet, there are measurable alterations to surfactant
biophysical function at relatively low surfactant concentrations in vitro compared to
surfactant isolated from standard diet fed rats. These collective biophysical alterations
imply that the diet may have had an effect on surfactant film fluidity. These biophysical
alterations were measured independently of amounts of cholesterol recovered in surfactant
and therefore it remains unknown which specific biochemical factors may be responsible
for the biophysical impairments. These biophysical observations support the findings that
a high cholesterol diet leads to significant alterations in surfactant function, however future
studies are required to equate these in vitro results to the in vivo setting.
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4.4 – Impact of VILI on Lamellar Body Surfactant
The impact of VILI on surfactant’s biophysical function has been extensively
examined in studies on the extracellular surfactant fraction obtained via lung lavage
(Greenfield et al., 1964; Verbrugge, 1999; Malloy et al., 2000; Veldhuizen et al., 2000;
Veldhuizen et al., 2002; Panda et al., 2004; Keating et al., 2007; Bailey et al., 2008;
Maruscak et al., 2008; Vockeroth et al., 2010). The role of VILI on the intracellular
surfactant (i.e. the lamellar body) has not been previously investigated. It is therefore
unknown as to whether intracellular production and packaging of surfactant into lamellar
bodies is altered during VILI which could contribute to the observed biophysical
impairments in extracellular surfactant. It was hypothesized that there would be alterations
to lamellar body surfactant recovery, composition, and biophysical function following
exposure to VILI. To test this hypothesis, lamellar bodies were isolated from rat lung tissue
homogenate after exposure to three experimental ventilation strategies. The results
demonstrated that minimum surface tension reduction of unravelled lamellar bodies
isolated from rats exposed to VILI was significantly impaired during early dynamic
compression-expansion cycles compared to non-injured controls. Secondly, the amount of
lamellar body associated phospholipids recovered from lung tissue was reduced following
exposure to VILI. Taken together, it is concluded that VILI causes significant alterations
to lamellar bodies. We speculate that these observed changes contribute to impairments in
surface tension reduction within the alveolar hypophase, thereby exacerbating lung injury.
To investigate the impact of VILI on intracellular surfactant within AIIEs, lamellar
bodies were isolated from rat lung tissue homogenate (Sanders et al., 1980) following
exposure to injurious ventilation with high VT and ZEEP based on previously described
experiments (Maruscak et al., 2008; Dreyfuss and Saumon, 1998). The model of VILI
utilized in this experiment was verified by indicators of pulmonary function, such as
reduced PaO2:FiO2 and increased PIP compared to control ventilation strategies,
demonstrating detrimental alterations in gas exchange and normal lung mechanics
following the ventilation period. Verification of lamellar body isolation technique was
confirmed by TEM visualization of lamellar body pellets isolated from non-ventilated rat
lungs. Within these images, lamellar bodies displayed dense lamellae structures surrounded
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by an intact limiting membrane and were without the presence of contaminating cellular
structures such as microsomes or mitochondria, suggesting a relatively pure fraction of
lamellar bodies had been isolated (Gil and Reiss, 1973; Post et al. 1981).

One of the objectives of our study, based on previous results of increased
cholesterol within endogenous surfactant obtained via lavage was to measure the relative
amount of cholesterol in the isolated lamellar bodies (see section 4.2.1; Panda et al., 2004;
Maruscak et al., 2008; Vockeroth et al., 2010). Our quantification of isolated rat lamellar
body cholesterol content (%phospholipids) was similar to that of previously published
studies in rats (Longmore and Hass, 1979: Orgieg and Daniels, 2001) and our analysis did
not indicate any difference in isolated lamellar body cholesterol content following exposure
VILI. Given the discord in relative cholesterol levels measured in extracellular and
intracellular surfactant following exposure to our rat model of VILI, it is proposed that
increases in extracellular surfactant cholesterol following alveolar over-distension and
collapse are not mediated through increased trafficking of cholesterol into lamellar bodies
prior to secretion into the airspaces.
The most likely explanation for the differences in cholesterol recovered between
intracellular and extracellular surfactant within our rat model of VILI arises due to
dysregulated exocytosis during large changes in alveolar surface area. Although lamellar
body luminal contents are unravelled into the air spaces to form the membrane surface
phase, dense phospholipid cores of lamellar bodies may not represent the primary storage
site for surfactant cholesterol within the AIIE (Orgeig et al., 2003). For example, injection
of radiolabelled cholesterol into the rat tail vein showed selective cholesterol accumulation
(3:1) in the lamellar body limiting membrane compared to the dense cores (Orgeig and
Daniels, 2001). Upon normal lamellar body exocytosis, the limiting membrane fuses with
AIIE plasma membrane and internal bilayers are expelled into the alveolar hypophase,
leaving the lamellar body limiting membrane its associated cholesterol at the cell
membrane (Ryan et al., 1975; Perez-Gil, 2008). Although cholesterol content in lamellar
body limiting membranes and luminal cores were not distinguished between experimental
groups in this study, it is speculated that high alveolar stretch may promote dysregulated
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exocytosis of lamellar bodies from lung tissue, potentially expelling cholesterol-rich
limiting membranes into the alveolar spaces along with other surfactant constituents.

Our assessment of lamellar body biophysical function on the CSD following VILI
is novel in two ways. Firstly, this experiment represents the primary investigation of
isolated lamellar bodies’ surfactant biophysical function on the CSD, providing an in-depth
assessment of adsorption and surface tension reduction during surface area cycling.
Although Haller’s group has successfully investigated lamellar body adsorptive capacity
and unravelling at the air-liquid interface using immunofluorescent labelled lamellar body
surfactant isolated from cell culture (Hobi et al., 2014; Hobi et al., 2016), our study builds
on these findings by subjecting lamellar bodies isolated in vivo to dynamic compressionexpansion cycles. Secondly, this study is the first assessment of intracellular surfactant
composition and biophysical function following exposure to VILI. Several studies have
investigated alterations to lamellar body composition following induction of lung injury
(Kirkland and Bray, 1988; Kirkland and Bray, 1989), however this is the first to do so from
a biophysical perspective. Intact lamellar bodies isolated in vivo are unravelled in vitro by
adding Ca2+ to surfactant buffer, allowing lamellar body surfactant to form multi-layer
structures in the presence of surfactant proteins, as would occur lining the lung extracellular
space (Engle et al., 1976). Our results indicate this method of functional assessment is not
only feasible for healthy lung lamellar bodies, as indicated by achievement of very low
surface tension (in some cases <1mN/m), but also has the sensitivity to detect biophysical
alterations in surfactant function that may occur as a result of injury as observed in our
samples obtained from rats exposed to VILI.
In our experiments, impairments in surface tension reduction were observed in
VILI samples during the early compression-expansion cycles, however continuous cycling
improved minimum surface tensions achieved over time. Therefore, lamellar bodies
isolated from VILI exposed rats were able to overcome their initial impairment by means
of several repeated compressions and expansions, as would occur during continuous
respiration. The phenomenon of improved surfactant surface tension reduction during
repeated lateral compression is likely explained by interfacial film remodelling, involving
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the continuous removal (or ‘squeeze out’) of fluidizing, unsaturated phospholipid and
cholesterol from the monolayer into the surfactant multi-layers below at each compression
(Zuo and Possmayer, 2007). This process promotes the formation of a DPPC enriched
membrane and is aided by surfactant proteins, presumably playing a role in the
organization of lipid domains within the surface membrane phase (Leonenko et al., 2007;
Lee, 2008; Perez-Gil, 2008). Our data lead us to suggest that upon film formation at airliquid interface, lamellar body surfactant isolated from NV or CV rats were able to
immediately form a DPPC enriched membrane upon the first compression, while lamellar
bodies from VILI exposed rats required several compressions to result in a more purified
surface membrane.
Given the myriad of studies investigating the biochemical and biophysical impact
of VILI on extracellular surfactant isolated from the lung via lavage, potential culprits
mediating impaired surface tension reduction of intracellular lamellar bodies may be
speculated. Previously, alterations to extracellular surfactant during VILI have been
described as: increased conversion of functional surfactant large aggregates to inactive
small aggregates (Veldhuizen et al. 2002; Bailey et al., 2008); altered expression of
surfactant proteins (Maruscak et al., 2008); serum protein leakage into the airspaces
competing with surfactant at the air-liquid interface (Veldhuizen et al., 2000; Maruscak et
al., 2008); and increased cholesterol incorporation into surfactant membranes (Panda et al.
2004; Vockeroth et al. 2010), all of which have been associated with altered surfactant
function to some degree. However, focusing our assessment on intracellular surfactant
allows for the exclusion of several of these factors that may impact extracellular surfactant
during VILI. For example, during alveolar over-distension, the pulmonary endothelialepithelial barrier permeability increases, promoting leakage of serum contents into the lung
airspaces (Dreyfuss and Saumon, 1998). Presumably, proteins that have leaked from the
serum bypass the lamellar body synthesizing AIIEs, moving directly into the airspace and
thus are likely not responsible for the interference of lamellar body surfactant function.
Furthermore, lamellar body surfactant material is believed to be composed strictly of large
aggregates, and thus conversion to small aggregates that occurs during surface area cycling
would not have occurred prior to assessment (Veldhuizen et al., 1996). Finally, our
investigation into levels of cholesterol in lamellar bodies yielded no difference between
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ventilation groups. Given the absence of differences between known mediators of
extracellular surfactant dysfunction, we suspect that intracellular alterations in the
production of phospholipids and surfactant proteins likely contribute to these biophysical
observed between VILI exposed samples and controls. Evidence for these types of changes
has been provided by Veldhuizen et al., who previously demonstrated the mRNA levels of
SPB and SPC in the lung tissue are reduced following exposure to VILI, suggesting
alterations in the transcription and production of these proteins intracellularly (2000).
Investigation into phospholipids species and proteins expression between samples is
required to confirm such speculation.

Although the primary finding of this study was altered biophysical quality of
surfactant isolated from lamellar bodies, it is suspected that quantitative changes to lamellar
bodies produced within the AIIEs also plays a role in the pathogenesis of VILI. Lamellar
bodies isolated from VILI exposed lungs had reduced recovery of surfactant phospholipids
suggesting reduced lamellar body phospholipid incorporation, increased lamellar body
secretion into alveolar airspaces, or both during instances of high VT and repeated alveolar
collapse. To further investigate the impact of VILI on lamellar bodies, a parallel study of
lamellar bodies in situ within lung tissue was performed. Using a similar experimental
design, lungs were fixed and TEM images of AIIE cells were obtained. These images were
analyzed for lamellar body morphological characteristics, numbers, and percent area
occupied within the AIIE. Results of this study are shown in Figure 4.1 and Figure 4.2,
respectively (personal communication with Reza Khazaee, data from unpublished
undergraduate thesis).
Representative TEM images of lamellar bodies visualized in situ within AIIE cells
are shown in Figure 4.1A. Generally there were no differences between ventilation groups
regarding lamellar body morphological characteristics such roundness, diameter, or
individual size, as assessed by Image Pro software (data not shown). However, lamellar
body staining intensity was significantly reduced in images of AIIEs exposed to VILI
(Figure 4.1B), suggesting to us that there was perhaps less surfactant phospholipid
incorporation into these lamellar bodies during ventilation with injurious strategies.
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Figure 4.1 – Representative TEM images of alveolar type II cells (AIIE) at 10,000X
magnification (scale bar represents 2µm), and in situ lamellar bodies at 46,000X
magnification (scale bar represents 100nm) imaged within rat lungs exposed to various
ventilation strategies (A). The intensity of stained materials (intensity/pixel) visualized in
lamellar bodies in situ within the AIIE (B).
from work by Reza Khazaee, unpublished).

#

indicates P<0.05, CV vs. VILI, n=3 (Adapted
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Quantification of in situ lamellar body number and % occupancy of the AIIE using
TEM image analysis is shown in Figure 4.2. Results were largely in accordance with what
was observed regarding phospholipid recovery of isolated lamellar bodies from lung tissue
(Figure 3.10A), namely, rats exposed to VILI had a significantly reduced number of
lamellar bodies visualized within the unit area of AIIEs images compared to CV and NV
animals (Figure 4.2A). AIIEs of NV and CV rats had similar absolute numbers of lamellar
bodies visualized in situ, however there was considerably less recovery of surfactant
phospholipid in lamellar bodies isolated from NV rat lung tissue homogenate compared to
CV. This discrepancy was resolved by investigation of lamellar body occupancy within
the AIIE (Figure 4.2B). Significant differences in lamellar body occupancy of AIIE were
observed between all three groups from TEM images obtained in situ, matching the trend
in recovered lamellar body phospholipid, such that lungs exposed to VILI had significantly
less lamellar bodies present in AIIE images compared to both control groups. Thus, overall
ventilation with high VT and ZEEP showed reduced lamellar body number, % area of
lamellar bodies occupying the AIIE, phospholipid recovery, and phospholipid staining
intensity, strongly indicating that this type of ventilation affects surfactant production and
assembly within the AIIE.
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Figure 4.2 – Number of lamellar bodies (LBs) (A) and relative area of AIIE occupied by
LBs (B) imaged in lungs isolated from rats following various ventilation strategies.
Results are presented as means ± SEM. * indicates P<0.05 – NV versus VILI, # indicates
P<0.05 – CV versus VILI. Φ indicates P<0.05 – CV vs NV, n=3/treatment group
(Personal communication, Reza Khazaee).
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The proposition that ventilation strategy impacts the amount of intracellular
lamellar bodies present within the AIIE is supported by additional reports claiming higher
levels of stretch promote increased surfactant secretion from the AIIE (Wyszogrodski et
al. 1975; Vlahakis and Hubmayr, 2003; Wirtz and Dobbs, 1990). Similar to the
supplementary in situ data presented, Massaro and Massaro showed diminished lamellar
body volume density within AIIE of rat lungs following just one hour of mechanical
ventilation with intermittent high VTs (Massaro and Massaro, 1983). The mechanism
behind these increases in lamellar body surfactant secretion during high VT ventilation was
proposed by Wirtz and Dobbs who demonstrated increasing magnitudes of stretch on rat
AIIE cells in culture produced a dose-dependent, transient increase in intracellular calcium,
correlated with higher levels of PC exocytosis (Wirtz and Dobbs, 1990). Overstretching of
the lung with higher tidal volumes favours lamellar body exocytosis, due to direct
stimulation of the AIIE calcium ion channels in response to changes in surface area (Dietl
et al., 2010). Given our observations regarding the alterations to lamellar body surfactant
recovered from lung homogenate in response to VILI and the fact high VT ventilation
promotes lamellar body exocytosis, we speculate lamellar bodies may be secreted into the
airspaces before complete phospholipid accumulation or maturation. These immature
lamellar bodies may not possess the complete set of surfactant constituents required for
biophysical function of maturated lamellar bodies. It is speculated that stimulated secretion
of pre-mature lamellar bodies may contribute to the biophysical impairments of
extracellular surfactant, worsening lung injury.

Despite the successful isolation of surface-active lamellar bodies from lung tissue
homogenate of VILI exposed rats, this study has several limitations. A limitation exists
that all previously described methods of lamellar body isolation were from healthy rat lungs
and thus it is unknown how or if the ventilation regimes would affect the surfactant
recovery during the isolation procedure. Our method for lamellar body isolation was
modelled after that of Sanders et al., 1980 and is dependent on the density of intact lamellar
body structures. Alterations in lamellar body density may have reduced the fraction of
material recovered at the 0.45-0.58M sucrose and thus we cannot be certain this technique
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was successful in isolating the complete set of lamellar bodies present in the lung.
Counteracting this argument is the morphological data which showed reduced lamellar
body content without major morphological differences, correlating well with our
phospholipid recovery data. Nevertheless, a more broad characterization of how VILI
affects surfactant density and recovery during isolation procedure requires investigation.

It should be noted that there are inherent limitations associated with our model of
VILI as it relates to the changes that may occur in humans undergoing mechanical
ventilation. Within the clinical setting, human patients that may be subject to mechanical
ventilation have pre-existing lung injury or ARDS responsible for impaired arterial
oxygenation and necessitating mechanical ventilation in the first place (Del Sorbo et al.,
2011; Ranieri et al., 2012). In this study, lung injury is initiated through alveolar overdistension and collapse associated with high tidal volumes (>25mL/kg) and 0 cmH2O
PEEP and as such, represents an unrealistic initiating insult as seen in the clinic setting.
Nonetheless, in cases where the lung may be heterogeneously injured or has regions of
collapse, physiologically low tidal volumes of 6mL/kg may pose risk toward subjecting
healthy lung regions to relatively large localized volumes causing alveolar over-distension
(Gattinoni et al., 1986). Although not directly applicable toward the initiation of ventilation
in human patients, this model of high tidal volume provides insight into effects of localized
over-distension on alveolar tissue responsible for assembling fresh surfactant into lamellar
bodies.

In summary, this study has extended knowledge regarding surfactant biophysical
impairments associated with VILI through demonstrating alterations to surfactant function
prior to secretion in the airspaces. These alterations suggest to us that overstretching and
collapse due to high tidal volumes and lack of PEEP, promote alterations to lamellar body
surfactant quality and quantity. In addition, we provide evidence that these impairments
are independent of cholesterol content, indicating elevated cholesterol in surfactant may be
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a relevant inhibitor of surfactant function only in the context of extracellular surfactant and
VILI.

4.5 – Novelty of the Constrained Sessile Drop Surfactometer
The use of the CSD to assess surfactant biophysical function of both extracellular
and lamellar body surfactant was one of the strengths of this thesis. For reasons discussed
in section 1.3.4.1 the CSD was the ideal surfactometer for assessing isolated rat surfactant.
By exposing surfactant to repeated dynamic compression-expansion cycles on the CSD,
changes in lung hypophase surface area during respiration are mimicked, allowing in vitro
assessment of isolated surfactant biophysical function such as adsorption, minimum
surface tension, and re-spreading capabilities. To date, only a handful of studies have
published their biophysical findings regarding surfactant obtained from experimental
animal models when assessed on the CSD (Ge et al., 2016; Otsubo et al., 2015; Yamashita
et al., 2016). The results obtained in this study indicating functional differences between
rats fed a standard and high cholesterol diet exposed to three models of ARDS, provide
supporting evidence to suggest the CSD as a particularly sensitive instrument capable of
detecting alterations to surfactant function assessed in vitro.
Intracellular surfactant biophysical function is largely ignored in experimental
studies of lung injury, as lavage surfactant has predominately been assessed to gain an
understanding of surfactant function at the air-liquid interface. Although extracellular
surfactant is directly responsible for the reduction of surface tension across the alveolus,
investigation into surfactant alterations as they occur intracellularly can provide valuable
insight into the pathology behind surfactant dysfunction, contributing to our understanding
of lung diseases. Our study represents the first investigation into the complete biophysical
function of isolated lamellar body surfactant. The ability to perform a detailed assessment
of adsorption and surface tensions during dynamic cycling on lamellar bodies is largely
due to the low sample requirement and delicate control of the compression area of the CSD.
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4.6 – Future Directions and Conclusions
In summary, we have characterized biophysical alterations to extracellular
surfactant following exposure to serum hypercholesterolemia, lung injury, and mechanical
ventilation, as well as impairments in surface tension reduction of lamellar body surfactant
isolated following exposure to VILI. Each of the two independent experiments offers
several frontiers of which future studies may be explored. Furthermore, the overall
conclusions of these experiments have provided a foundation upon which future
experiments may be based.

4.5.1 – Impact of Diet-Induced Serum Hypercholesterolemia
Considering our results demonstrating biophysical alterations to surfactant
following exposure to a high cholesterol diet, there are several future directions that may
be undertaken which may help determine a biochemical culprit responsible for altered
surfactant function. An immediate future direction would be to quantify the various
phospholipids present in the isolated surfactant samples using liquid chromatography-mass
spectrometry. This would provide the relative quantities of PC, PG and other minor
phospholipids, as well as the relative fatty acid profiles of each, present in surfactant. Based
on biophysical differences measured in our study, it is suspected a high cholesterol diet
may have reduced DPPC or increased unsaturated phospholipid content, in some unknown
manner altering membrane fluidity. It is also worthwhile to determine if there are any
alterations to SPA, SPB, and SPC expression recovered in lavage using western blot and
densitometry as these proteins may also impact dynamic surfactant function (Perez-Gil,
2008), and may be altered during various patterns of stretch (Veldhuizen et al., 2002;
Vlahakis and Hubmayr, 2003; Maruscak et al., 2008). Assessment of these experimental
outcomes would provide a complete quantitative assessment of surfactant film constituents
isolated from rat lavage exposed to these diets. Determining the precise composition of
these surfactants may help to resolve the functional differences observed between lavage
isolates from rats fed a standard and high cholesterol diet and may further infer a risk factor
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of serum hypercholesterolemia toward the development of dysfunctional surfactant and
potential lung injury.

Although this thesis has presented findings regarding diet-induced changes to
surfactant function, the diet used was limited in its relatively short duration. To this end,
the role of chronically elevated serum cholesterol towards alterations of surfactant function
and lung physiology within animal models and human populations should be assessed.
Extending the duration of diet and applying it to the experimental design used in the initial
diet study, the impact of long-term serum hypercholesterolemia may be assessed to give a
better indication as to whether serum hypercholesterolemia is truly a relevant risk factor
for the development of ARDS in humans. In addition, investigating other causes of serum
hypercholesterolemia, such as genetic polymorphisms (Bender et al., 2012), may further
provide evidence of a risk factor associated with the development of lung injury.
Using three independent models of lung injury, we have demonstrated cholesterol
may be a specific biomarker indicative of exposure to injurious ventilation or VILI.
Although there is preliminary evidence to suggest high levels of cholesterol may play a
role in surfactant alterations and dysfunction in human patients receiving mechanical
ventilation (Markart et al., 2007; Qua Hiansen et al., 2015), this remains to be tested. A
future study may be directed at determining whether ARDS patients on the ventilator may
have alterations to surfactant cholesterol content in vivo over the course of mechanical
ventilation. This could be investigated by recruiting newly diagnosed ARDS patients and
obtaining a lavage sample around the time supportive mechanical ventilation is initiation.
These patients may then be monitored closely over the duration of mechanical ventilation
and a second lavage sample may be obtained at a time point following significant exposure
to mechanical ventilation. Once lavage samples pre and post mechanical ventilation have
been obtained, comparisons may be made to determine if the amount of cholesterol in
surfactant isolated by lavage increased over the course of ventilation.
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4.5.2 – Impact of VILI on Lamellar Body Surfactant
In this thesis, we provide a novel investigation into lamellar body surfactant
biophysical activity isolated from lungs exposed to various ventilation strategies. It was
found that crude lamellar bodies isolated from rat lungs after exposure to VILI produced
significant impairments in surface tension reduction at early cycles. Although we speculate
these alterations occurred due to altered surfactant protein expression or phospholipid
species present in lamellar body samples, this has not been investigated. Therefore, an
immediate future direction is to measure isolated lamellar body phospholipid species and
surfactant protein expression using mass spectroscopy and western blots, respectively.
Complete characterization and quantification of surfactant constituents may help determine
any pathological alterations to AIIE intracellular signalling during surfactant production
and processing in response to overstretching, helping to characterize the detrimental
changes that occur to human patients’ lungs during VILI.
Furthermore, because the assessment of lamellar body’s biophysical properties by
CSD had not been completed before this study, it is worthwhile to assess the lamellar body
biophysical function on the CSD following lipid extraction. Using chloroform and
methanol extraction (Bligh and Dyer, 1959), surfactant phospholipids and hydrophobic
proteins SPB and SPC may be separated from other hydrophilic proteins or possible
contaminants that may have accumulated with the lamellar body samples during the
isolation procedure. If similar trends regarding the surface tension reduction of extracted
lamellar bodies isolated from VILI exposed animals are observed compared to crude
samples, this assessment will further solidify the findings that there are alterations to the
biophysical properties of lamellar bodies, removing the possibility of interfering
contaminants. In addition, because the majority of SPA is secreted independently of
lamellar bodies (Ochs et al., 2002) and removed during the extraction process, the impact
of adding SPA (5%w/w PL) to extracted lamellar body samples should be examined. The
addition of SPA enhances surfactant biophysical properties in the presence of SPB,
contributing to the enrichment of DPPC membranes during compression and improving
interfacial surface active properties (Schürch et al. 1992). Thus, it is possible that adding
SPA to lamellar bodies isolated from VILI exposed animals may improve minimum
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surface tension achieved upon early compressions. This type of differential assessment of
surfactant biophysical properties may lead to an understanding of how surfactant
impairments during VILI are mediated and may further provide insight into how these
impairments may be mitigated.
Alterations to intracellular surfactant within the context of ARDS have largely not
been studied. Given the excellent surface tension reducing capabilities of lamellar bodies
isolated from naive rat lung tissue homogenate and the measurable impairments following
exposure to VILI in vitro on the CSD, we propose future animal studies investigating the
impact of ARDS on surfactant function should not neglect to assess lamellar body
surfactant biophysical function. Assessment of intracellular surfactant function within
lamellar bodies remains a potentially fruitful area of investigation for surfactant research
in order to indicate alterations to the way AIIE cells handle surfactant synthesis, packaging,
and secretion into the airspaces. This sort of biophysical and compositional assessment
may be applied to other causes of ARDS (such as gastric acid aspiration) to determine the
various intracellular effects on AIIE surfactant production induced by various models of
lung injury. Distinguishing intracellular alterations to surfactant during various insults of
injury may help to provide beneficial therapy for patients targeted to their specific cause of
the injury.

4.5.3 – General Future Directions
In past experiments using rat models of VILI, supra-physiological levels of
cholesterol have been observed in lavage surfactant (Panda et al., 2004; Maruscak et al.,
2008; Vockeroth et al., 2010). In this study, we have provided evidence that these changes
are likely a consequence of the damaging effects of injurious ventilation on the lung.
Despite the consistency of this observation, the physiological and molecular mechanisms
behind these pathological changes to cholesterol regulation remain unknown. Specifically,
it remains to be determined which forces acting upon the alveoli contribute toward
cholesterol dysregulation in the AIIE in our model of VILI. By studying rats grouped to
different ventilation strategies with varying degree of alveolar over-distension (dependent
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on the level of VT and PEEP applied) and shear forces at each breath (PEEP vs. ZEEP),
the mechanism of injury in which cholesterol is increased in surfactant may be elucidated.
Determination of the ventilator setting that contributes to these cholesterol mediated
surfactant biophysical impairments may help in developing superior protective ventilation
strategies to help prevent these adverse consequences and improve the patient mortality
associated with mechanical ventilation of ARDS patients.
In addition to the ventilation parameters responsible for elevated surfactant
cholesterol, the molecular mechanisms behind the increased incorporation of free
cholesterol into surfactant extracellular films within the AIIE are unknown. In this thesis,
we have provided evidence to suggest that during VILI 1) excessive cholesterol does not
become increased in surfactant due to leakage from the serum, and 2) surfactant cholesterol
is not increased intracellularly within lamellar bodies as a whole prior to secretion. Thus to
gain a complete understanding of cholesterol regulation and metabolism within the AIIE
in response to VILI, other storage localizations for alveolar cholesterol within the AIIE
such as the cytoplasm, lamellar body limiting membrane, and lipofibroblasts should be
investigated (Orgeig and Daniels, 2001) to gain a broader understanding of how this type
of injury impacts the surfactant synthesizing cells. Cholesterol metabolism within the AIIE
involves a variety of differentially expressed proteins responsible for cholesterol
internalization and export and from the serum. Specific focus for future studies may be
determining changes in AIIE expression to proteins like ABCA1, and ABCA3 during
various levels of mechanical stress, as these proteins regulate the movement of cholesterol
from the serum into the AIIE and further regulate cholesterol during lamellar body
formation (Perez-Gil and Weaver, 2010; Bates et al., 2005). The overall lack of
understanding of AIIE intracellular cholesterol transport highlights the need to understand
the storage and liberation of alveolar intracellular cholesterol. Determining the expression
patterns of protein in response to various levels of alveolar stretch may help to provide a
molecular basis for the increased trafficking of cholesterol to surfactant during VILI. Once
these molecular targets have been established, pharmacological measures may be
undertaken to attempt to control the amounts of surfactant cholesterol during mechanical
ventilation, helping to reduce surfactant dysfunction.
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4.5.4 – Overall Conclusions
In conclusion, the two major findings of this thesis are 1) diet-induced serum
hypercholesterolemia during experimental lung injury promotes biophysical alterations to
surfactant isolated from rat lavage compared to rats fed standard diet, and 2) VILI promotes
significant alterations to lamellar body surfactant biophysical function prior to secretion
into the airspaces. These results emphasize the detrimental changes that occur to surfactant
function during injurious ventilation and provide novel insight into the functionality of
intracellular surfactant before secretion into the airspaces. Furthermore, these experiments
attempt to resolve the mechanism by which surfactant cholesterol content is increased
following VILI. While they unfortunately do not provide a direct answer, they provide
valuable insight into the regulation of cholesterol within the AIIE. Given the effects of
altered surfactant composition and function toward impaired respiratory mechanics, it is
important to understand how these biophysical changes are mediated within the lung.
Ultimately, understanding these changes may help to develop therapeutics which may
prevent or mitigate these adverse consequences, and improve overall patient survival.
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